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Summery 
A high throughput, robust, simple, and economic bioanalytical method for simultaneous 
determination of nicotine (Nic), cotinine (Cot) and nicotine N-oxide (Nox) in human 
urine, plasma, semen, sperm and dried blood spot (DBS) was developed and validated by 
LC ESI-orbitrap-MS. The current described method was successfully developed using 
deuterated nicotine (nicotine-d3) as internal standard (IS) following single extraction step 
by trichloroacetic acid solution (TCA) for protein direct precipitation, providing top 
extraction recovery and short run time with accurate mass measurements. The method 
was then validated according to the European and American guideline for bioanalytical 
method validation in terms of specificity, matrix effect, linearity, sensitivity, precision, 
accuracy and stability. Chromatographic conditions were optimized using Kinetex-C18 
column (150 × 2.1mm, 5µm) and eluted by mobile phase of methanol:water:formic acid 
(10:90:0.1%, v/v/v).  
 
Accurate mass measurements were obtained by ESI-orbitrap-MS at positive m/z 
163.1235, 177.1028, 179.1188 and 166.1423 for Nic, Cot, Nox and IS, respectively. The 
established calibration range for Nic, Cot and Nox in urine analysis was linear between 
50 and 3000 ng/mL, in plasma, semen and DBS was linear between 5-250 ng/mL for Nic 
and Nox, and between 10-500 ng/mL for Cot. The within and between days 
measurements precision and accuracy were all within the acceptance criteria according to 
the European and American guidelines for bioanalytical method validation, and the 
extraction recovery was higher than 95% for the studied matrixes. The ionic suppression 
test was achieved and discussed for the all investigated fluidic matrices. 
 
The established method was intended to investigate three objectives, including study the 
influence of pomegranate and licorice test drinks on Nic metabolism rate. This was done 
by urinary measurements for metabolic index of Nic/Cot, in addition to new introduced 
metabolic index Nic/Nox, where urine samples were collected from twenty four smoker 
volunteers under pomegranate and licorice drink conditions, and compared their 
measurements to corresponding control condition. 
 
 
 
 
The second study objective was intended to investigate Nic with its major metabolites 
Cot and Nox availability in human plasma, semen and sperm, where Nic has extensive 
distribution among human fluids and tissues, but still nobody knows whether Nic is 
available in sperm or not. Herein, sperm bodies were separated quantitatively from each  
1 mL of twelve human’s semen samples by centrifugation and extracted. As a result, Nic 
and Cot were detected in all samples, and Nox was below the LLOQ in plasma but 
detectable in all semen samples and 10 out of 12 sperm samples. Interestingly, Nic was 
significantly higher in semen compared to plasma (2.3-fold, p<0.001). The measured Nic 
and Cot concentrations in sperm samples were comparable to the corresponding 
measurements in plasma, and Nic was significantly lower in sperm compared to semen 
(2.1-fold, p<0.001).  
 
The third study objective was intended to find a suitable bioanalytical method using DBS 
technique as an alternative to the traditionally used methods. A 6.35 mm disk diameter 
was cut out of the filter cards and extracted by TCA solution in a single extraction step. 
Chromatographic effect was investigated in current study and demonstrated that the 
overall variation accounted due to decentralized punch and hematocrit effects are caused 
a minimal variation factor in Nic and Cot quantitation by DBS. The optimized method 
was then applied to collect blood samples from twelve smoker volunteers, and compared 
their DBS measurements with the corresponding plasma measurements.  
 
 
 
 
 
 
 
 
 
 
 
 
Zusammenfassung 
In dieser Arbeit wurde eine durchsatzstarke, robuste, einfache und ökonomische 
bioanalytische Methode für die simultane Analyse von Nikotin (Nic), Cotinin (Cot) und 
Nikotin N-oxid (Nox) in menschlichem Urin, Plasma, Samenflüssigkeit, Sperma und 
getrockneten Blutproben (engl. dried blood spot, DBS) mit LC-ESI-orbitrap-MS 
entwickelt und validiert. Zum Ausfällen der Proteine wurde ein einzelner 
Extraktionsschritt mit Trichloressigsäure (TCA) eingesetzt und als interner Standard (IS) 
diente deuteriertes Nicotin (nicotine-d3). Die entsprechend der europäischen und 
amerikanischen Richtlinie für bioanalytische Methodenvalidierung hinsichtlich 
Spezifität, Matrixeffekt, Linearität, Sensitivität, Präzision, Genauigkeit und 
Lagerstabilität validierte Methode zeigt hohe Wiederfindungsraten, weist kurze 
Analysenzeiten auf und liefert akkurate Massen der Analyten. Nach Optimierung der 
chromatographischen Bedingungen wurde eine Kinetex-C18 Säule (150 x 2.1 mm, 5 µm) 
mit Methanol:Wasser:Ameisensäure (10:90:0,1 %, v/v/v) als Laufmittel eingesetzt. 
Mittels ESI-orbitrap-MS wurden akkurate Massen im Positivmodus aufgenommen. Bei 
der Auswertung wurden die m/z-Verhältnisse 163,1235, 177,1028, 179,1188 und 
166,1423 für die Substanzen Nic, Cot, Nox bzw. IS herangezogen. Der lineare Bereich 
für Nic, Cot und Nox in Urin lag bei 50-3000 ng/mL. In Plasma, Samen und bei den DBS 
wurde ein linearer Bereich von 5-250 ng/mL für Nic und Nox sowie von 10-500 ng/mL 
für Cot festgestellt. Präzision und Genauigkeit der Messungen entsprachen den Kriterien 
der angewandten Richtlinien und die Wiederfindung nach der Extraktion lag für alle 
Matrices bei über 95 %. Die Ionensuppression wurde für alle untersuchten Matrices 
getestet und bewertet. 
 
Mit der entwickelten Methode wurden in dieser Arbeit drei Fragestellungen bearbeitet. 
Als erstes wurde der Einfluss von Granatapfel- und Lakritzgetränken auf die 
Metabolisierungsrate von Nikotin anhand von Bestimmungen des metabolischen Index 
Nic/Cot sowie eines zusätzlichen neuen, in dieser Arbeit erstmalig verwendeten Index 
Nic/Nox, in Urin untersucht. Im Vergleich mit den entsprechenden Kontrollbedingungen 
 
 
 
 
zeigte sich bei den 24 Raucherprobanden unter dem Einfluss von Granatapfel- und 
Lakritzgetränken eine beschleunigte Metabolisierungsrate von Nikotin.  
 
Im zweiten Teil dieser Arbeit wurde der Gehalt von Nikotin und seinen Hauptmetaboliten 
Cotinin und Nikotin-N-Oxid in menschlichem Plasma, Samenflüssigkeit und Sperma 
untersucht. Nikotin verbreitet sich im menschlichen Körper in Flüssigkeiten und 
Geweben, aber es ist bisher nicht bekannt, ob Nikotin in Sperma vorhanden ist. Dazu 
wurden Spermienzellen aus je 1 mL Spermienflüssigkeit von 12 Probanden durch 
Zentrifugation quantitativ abgetrennt und mittels der optimierten Methode extrahiert. 
Nikotin und Cotinin wurde in allen Proben detektiert. In Plasma lag der Gehalt von 
Nikotin-N-Oxid unterhalb der Quantifizierungsgrenze, in allen Samenflüssigkeitsproben 
und in 10 von 12 Spermaproben konnte Nox aber detektiert werden. Der Nikotin- und 
Cotiningehalt in Sperma war mit dem Gehalt in Plasma vergleichbar. In Samenflüssigkeit 
war der Gehalt an Nikotin signifikant höher als in Plasma (2,3-fach, p<0.001). Im Sperma 
lag die Konzentration von Nic und Cot im gleichen Bereich wie für Nic im Plasma. Die 
Nic-Konzentrateion im Sperma war jedoch signifikant niedriger als in der 
Samenflüssigkeit (2,1-fach, p<0,001).  
 
Im dritte Teil dieser Arbeit wurde eine bioanalytische Methode unter Verwendung von 
getrockneten Blutproben (DBS) als Alternative für traditionell eingesetzte Methoden 
entwickelt. Die auf Filterpapieren getrockneten Blutproben wurden als Plättchen von 6,35 
mm Durchmesser ausgestanzt und mit Trichloressigsäure in einem einzelnen 
Extraktionsschritt extrahiert. Die Untersuchung chromatographischer Effekte zeigte, dass 
Variationen der DBS Methode durch nicht exakt zentriertes Ausstanzen der Bluttropfen 
und hämatokritische Effekte nur zu minimalen Schwankungen der ermittelten Nikotin- 
und Cotiningehalte führen. Anschließend wurde die optimierte Methode auf Blutproben 
von zwölf Rauchern angewandt und die Messungen mittels DBS wurden mit den 
entsprechenden Plasmaproben verglichen. 
 
 
 
 
 
 
Table of Content 
1    Introduction………………………………………………………..……..………...1 
1.1    Nicotine Overview………………………………………………………………1  
1.1.1     Nicotine Absorption and Distribution………………………………………2 
1.1.2     Nicotine Metabolism…………………………………………..…...……….2  
1.1.3     Nicotine’s Adverse Health Consequences………………………....……….4 
1.1.4     Nicotine Impact on Human Reproduction………………………...………..4 
1.2    Pomegranate Fruit Identification and Enzymatic Interactions……..…...……….5 
1.3    Licorice Root Identification and Enzymatic Interactions………………..……...6 
1.4    Pomegranate, Licorice and Nicotine Interactions……………………..………...8 
1.5     Nicotine Analysis in Human……………………………….…………….........9 
1.5.1    Methods of Extraction……………………………………………………...10 
1.5.2    Analytical Techniques………….………………………………………….11 
1.5.3    Orbitrap-MS………………………………………………………………..12 
1.5.4    Dried Blood Spot…………………………………………………………..13 
1.5.5    Investigated Nicotine in Human Fluids and Tissues……….……………....14 
1.6    Bioanalytical Method Validation……………………………………...……….15 
1.6.1    Selectivity (Specificity) and Carryover……………………………………15  
1.6.2    Matrix Effect and Recovery………………………………………………..16 
1.6.3    Calibration Curve linearity………………….……………………………..17  
1.6.4    Precision and Accuracy…………………………………………………….18 
1.6.5    Stability…………….………………………………………………………18 
1.7    Work Objectives and Significance…………………………………………......19 
2    Study the Influence of Licorice and Pomegranate Drinks on Nicotine Metabolism             
in Human Urine……………………………………………………………………..37 
2.1    Introduction………………………………………………………………….....37  
2.2     Experimental…………………………………………………………………..38 
2.2.1    Chemicals and materials……………….…………………………………..38 
2.2.2    Instrumentation……….…………………..………………………………..38 
2.2.2.1     HPLC conditions…..…………………………………………………..38 
 
 
 
 
2.2.2.2    Mass spectrometric conditions……………………….……..….………39 
2.2.3    Standard solutions, calibration curve and QC Samples…………..…..……39 
2.2.4    Sample preparation…………………………………….……………….….39 
2.2.5    Bioanalytical method validations……………………………..……….…...39 
2.2.5.1    Linearity, accuracy and precision……………………………………...40 
2.2.5.2    MS ionic suppression…………………………….…………………….40 
2.2.5.3    Recovery and stability……………………………………………….....40 
2.2.6    Preparation of pomegranate juice and licorice drink………………….…...41 
2.2.7    Study Design…………………...…………………………………………..41 
2.3    Results and discussion……………………………………………..…...42 
2.3.1    Orbitrap-MS analysis……….……………………………………………...42 
2.3.2    Chromatographic separation specificity…………………………………...43  
2.3.3    Ion suppression and Matrix effect………………………………………….43 
2.3.4    Standard calibration curve linearity……………………..…………………43 
2.3.5    Within-and between-run sensitivity, accuracy and precision………….…..46 
2.3.6    Recovery and stability……………………………………………………...47 
2.3.7    Study applications………………………………………………………….47 
2.4    Conclusion……………………………………………………………………..49 
3    Simultaneous determination of nicotine, cotinine and nicotine N-oxide in human 
plasma, semen and sperm by LC-Orbitrap-MS………..……………………………55 
3.1    Introduction…………………………………………………………………….55 
3.2    Experimental…………………………………………………………………...56 
3.2.1    Chemicals and reagents……………………………………………………56 
3.2.2    Instrumentation…………………………………………………………….56 
3.2.2.1     HPLC conditions………………………………………………………57 
3.2.2.2    Mass spectrometric conditions…………………………………..……..57 
3.2.3    Standard solutions, calibration curve and QC Samples……………………57 
3.2.4    Sample preparation………………………………………………….……..58 
3.2.4.1    Subjects…………………………………………………………….…..58 
3.2.4.2    Semen and plasma extraction……………………….………………….58 
3.2.5    Bioanalytical method validations……………….………………………….58 
 
 
 
 
3.2.5.1    Linearity, accuracy and precision……………………………………...59 
3.2.5.2    Matrix effect, recovery and stability…………………………….……..59 
3.3    Results and discussion…………………………………………………………60 
3.3.1 Orbitrap–MS analysis……………………………………………………..60 
3.3.2 Chromatographic separation and matrix effect…………………….……..60 
3.3.3 Standard calibration curve linearity………………………………….…...64 
3.3.4     Sensitivity, accuracy, and precision……………………………………….64 
3.3.5 Recovery and stability…………………………………………………….65 
3.3.6 Application………………………………………………………………..66 
3.4 Conclusion…………………….…………………………………………………68 
4 Determination of nicotine and cotinine in human blood by dried blood spot/ LC-
Orbitrap MS technique……………………………………………………………...74 
4.1    Introduction…………………………………………………………………….74 
4.2    Experimental………………………………………...…………………………75 
4.2.1    Chemicals and reagents…………………………………………………….75 
4.2.2    Instrumentation…………………………………………………………….76 
4.2.2.1    HPLC conditions……………………………………………………….76 
4.2.2.2    Mass spectrometric conditions…………………………………………76 
4.2.3    Standard solutions, calibration curve and QC Samples……………………76 
4.2.4    Sample preparation…………………………………………………...……77 
4.2.5    Method validations………………………………...……………………….77 
4.2.5.1    Linearity, accuracy and precision……………………………………...77 
4.2.5.2    Ion suppression, Matrix effect……………….………………………...78 
4.2.5.3    Recover………………………………………………………………...78 
4.2.5.4    Stability………………………………………………………………...78 
4.2.5.5    Chromatographic effect and decentralized DBS punching…………….79  
4.3    Results and discussion…………………………………………………………79 
4.3.1    Orbitrap–MS analysis……………………………………………………...79 
4.3.2    Chromatographic separation, ion suppression and matrix effect…….…….80 
4.3.3    Standard calibration curve linearity…………………………………...…...82 
4.3.4    Within-and between-run sensitivity, accuracy and precision……………...82 
 
 
 
 
4.3.5    Recovery and stability……………………………………….….………….83 
4.3.6    Chromatographic effects…………………………………………..……….84 
4.3.7    Application…………………………………………………….….………..85 
4.4 Conclusion………………………………………………………………….……87 
5 Overall conclusion…………………………………………………….….…….91 
6 Appendix…………………………………………………………………..……93 
6.1 Supplementary material for chapter 3.2.4.1……………………….………...94 
6.2 Preventative calibration curves including chromatograms…………….…….94 
6.3 List of abbreviations………………………………………………..…..…..101 
6.4 List of figures………………………………………………………..……...104 
6.5 List of tables……………………….………………………………………..106 
6.6 Publication list……………………………………………………………...107 
6.7 Curriculum vitae …………………………………………………………...109 
6.8 Erklärung …………………………………………………………………...110 
6.9 Acknowledgment……………………...……………………………………111 
 
 
 
 
 
 
 
 
 
 
 
1 
 
 
 
1 Introduction 
 
1.1 Nicotine Overview  
Nicotine (Nic), chemically 3-(1-methyl-2-pyrrolidinyl) pyridine, is a tertiary amine 
structured from a pyridine and a pyrrolidine ring (C10H14N2, Figure 1.1 A) and a colorless 
to pale yellow oily liquid with boiling point 247 °C and exact mass 162.115698 g/mol 
[1]. Nic occurring naturally as a major alkaloid compound in tobacco leaves and consists 
about 95% of the total alkaloid content [2, 3].  
Nic has historically known since centuries, it was described and reported in 1571 [4], and 
first determined from tobacco leaves was in 1828 [5]. In spite of negative effect for Nic 
on human health, it has a high consumption rate around the world, and it becomes 
provided commercially in many products including tobacco, pesticide [6–8] and Nic 
replacement therapy (NRT) [9].  
 
 
Figure 1.1 Chemical structure of Nicotine (Nic, A), Cotinine (Cot, B), Nicotine-N-oxide 
(Nox, C) and deuterated Nicotine (Nic-d3, D). 
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1.1.1 Nicotine Absorption and Distribution 
Nic is a weak base with a pKa of 8.0, it will be absorbed rapidly through biological 
membranes in basic medium (in non-ionized form), it can be absorbed through oral 
cavity, skin, lung, urinary bladder, and gastrointestinal tract depending on the absorption 
environmental pH [10]. In smokers, the suspended Nic in smoking main stream mainly 
absorbed in lung and mouth cavity [11], and the highest absorption fraction through 
inhalation occurs in lung (60 % to 80 % of Nic intake [3]), due to the high surface area of 
lung alveoli, and facilitated absorption across cell membranes through basic medium (pH 
≈ 7.4), whereas 30%  of Nic being non ionized, and its binding affinity to plasma proteins 
is around 5% [11]. 
Following Nic absorption, it enters bloodstream and reaches the systemic circulation, 
then crosses the placental barrier easily to reach brain within 20 s. 
Nic with its metabolites distributed extensively among human fluids and tissues and 
determined in smoker’s autopsy tissues of brain, lung, liver, kidney, muscle [12, 13], 
spleen, abdominal, thigh, adipose [13]. Tricker has described Nic occurrence in human 
body in details [14], and he also described a variety of analytical techniques used in 
biomarkers determination derived from Nic and its metabolites, where most of biological 
fluids and matrices were investigated such as blood, saliva, urine, follicular fluid, fetal 
fluids, seminal plasma, sweat [14], hair [15], breast milk [16], cervical mucus [17], 
toenail and the deciduous teeth [18] and bones [19]. But still no described investigation 
whether Nic or its biomarkers cotinine (Cot) and nicotine N-oxide (Nox) are available in 
the sperm bodies or not, and only limited studies were reported by Tricker for Nic or Cot 
analysis in seminal plasma [20–22]. 
 
1.1.2 Nicotine Metabolism 
Nic metabolism occurs in human liver mainly by cytochrome p450 (CYP) 2A6 to its 
major metabolites Cot and Nox [23–25] and many other metabolites as illustrated in 
Figure 1.2 [26, 27]. CYP2B6 is another responsible isoform about Nic metabolism, but it 
accounts around 0.2% of human liver CYPs [29] and plays a minor and conditional role 
in Nic metabolism [25, 30], especially at high Nic concentration [28]. CYP2A13 is also 
another minor metabolizer for Nic in a certain conditions [31]. 
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Figure 1.2 Percentage quantitative illustration scheme for Nic metabolism, estimated 
from total urinary excretion, modified by [26, 27].  
  
The CYP2A6-catalyzed metabolism for Nic involves two steps; first, C-oxidative 
transformation to produce Nic-iminium ion, in equilibrium with hydroxyl-Nic. The 
second step is an aldehyde oxidation to produce the principal metabolites Cot in 70–80%, 
and Nox in 4–7% [32]. Cot undergoes further metabolism steps to produce 3-hydroxy-
Cot (3HC) in 33–40%. Nox has no further metabolism evidence, except its back 
conversion to Nic in the intestines in low recycling level [11].  
Nic metabolism is variable among human subjects, in addition to genetic wild-type 
CYP2A6 [30] and CYP2A6 genetic variability factor [33], there are many other factors 
affecting Nic metabolism rate, including physiological influences, such as diet and meals 
[34, 35], age, gender, pregnancy [36], menstrual cycle in women, kidney disease and 
sleeping [11].  
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Synchronized ingestion of medications or phytochemicals with Nic intake is also a 
significant factor that affecting Nic metabolism, where such chemicals are metabolized 
mainly in liver, and they have interactions with hepatic CYPs [36] which could lead to 
inhibit Nic metabolism or to stimulate its metabolism rate by induction effect. 
There are many examples from the literatures for inhibited Nic metabolism by 
phytochemicals derived from grapefruit [37], mint drink [38] and many other compounds 
[28], and the accelerated Nic metabolism by the mean of induction effect has also 
reported, such as phenobarbital and other anticonvulsant drugs [11]. On the other hand, 
the accelerated drugs metabolism by induction effect has occurred by Nic [39, 40], and 
the inhibited metabolism rate for some other drugs were also reported [41]. 
 
1.1.3 Nicotine’s Adverse Health Consequences 
Nic has a wide adverse health consequences [42, 43], especially if taken in high doses 
[44, 45]. It’s an addictive drug [46], which makes difficulties in stop smoking cigarettes 
[47, 48]. In addition to its health consequences, Nic has been used as insecticide due to its 
poisoning capabilities [8, 49–51], where insects are not reaching tobacco leaves and 
farms in nature. 
In spite of no evidence for Nic impact on human health - as shown from epidemiological 
studies relating to the use of Swedish type moist snuff (as Nic supplement) [52] - a lot of 
studies were correlated using smokeless tobacco to adverse health consequences [53], e.g.  
the induction of many cancers by Nic [54], disability and early death [55]. 
 
1.1.4 Nicotine Impact on Human Reproduction 
In addition to Nic’s adverse health consequences profile, it has a particular impact on 
human reproduction as well [56, 57]. Many studies are correlating smoking cigarettes to 
males infertility, in terms of influenced testicular function and semen quality [58], 
reduced sperm production, sperm motility, sperm normal forms and sperm fertilizing 
capacity through increased seminal oxidative stress and DNA damage [59–66]. More 
accurate in vitro-based studies for Nic effect on human infertility was also correlated with 
Nic intake on sperm membrane, DNA integrity and viability [67]. In addition to its 
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genotoxic impact on chromosomes of human fetal cells [68], another animals-based study 
about Nic oral dose-dependent effect on sperm characteristics and fertility of  male rats 
showed a significant decrease  in sperm motility and count for treated rates compared 
with untreated control rates. More indications were also reported by measuring Nic [69] 
and Cot [21] levels in seminal plasma, but still nobody knows whether or not Nic or its 
biomarker Cot or Nox is available in sperm bodies, which could be directly correlated to 
human infertility. 
 
1.2 Pomegranate Fruit Identification and Enzymatic Interactions 
A highly popular functional food of pomegranate fruit, has been considered as super fruit, 
due to its antioxidant constituents and diseases resistant [70] with many of its therapeutic 
applications [71].  
Chemically, the phytochemicals derived from pomegranate are ellagitannins 
(punicalagin), pelargonidin, punicalin, anthocyanins, cyanins (cyanins day), ellagic acid 
as shown their chemical structures in figure 1.3 [72] and certain species of flavonoids 
(figure 1.4) [73]. 
The studies on pomegranate inhibition effect for CYP 3A4 [74] found a comparable 
inhibition potency with grapefruit juice [75, 76], in addition to its minor inhibitory effect 
for CYP 2C9, CYP 1A2 and CYP 2E1 [77]. 
Therefore, pomegranate juice has a potential interactions with the drugs [78], such as 
warfarin [79], tolbutamide [80] and carbamazepine [75], which impairs their metabolic 
activity pathway. 
 
6 
 
 
 
 
 
Figure 1.3 Chemical structure for phytochemicals derived from pomegranate fruit.  
 
 
1.3 Licorice Root Identification and Enzymatic Interactions 
Licorice originated in the Mediterranean, native to southern Europe and parts of Asia and 
has been used medically to treat many health disorders [81]. It is the most frequently used 
herbal medicines over worldwide, and known as herbs grandfather, due to its vast 
biomedical applications [82], it contains to glycyrrhizin, which is 50 times sweeter than 
sucrose. 
Chemically, licorice contains phytochemicals (as shown in figure 1.4) of triterpene 
glycosides (including glycyrrhizin or glycyrrhitic acid), polysaccharides, flavonoids, 
coumarin derivatives, formononetin [83] and glabridin [84]. 
 
7 
 
 
 
 
Figure 1.4 Chemical structure for phytochemicals derived from licorice root.  
 
The phytochemicals of isoflavan and glabridin derived from licorice root inhibit the 
activities of human CYP 3A4, 2B6, 2C9 [29], 1A2, 2C19 and 2D6 [82], which are 
responsible for 80% of known drugs metabolism [85]. Many studies are demonstrating 
positive effect for licorice in therapeutic applications [86, 87], due to its strong and 
variable interactions with hepatic CYPs, that lead to clinical-relevance for the prescribed 
drugs [88]. 
 
Licorice metabolism occurred mainly by CYP 3A4, which metabolizes more than 50% of 
clinically used drugs [29]. There are many inhibited drugs metabolism in presence of 
licorice [89], and its induction effect was also reported [90].    
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1.4 Pomegranate, Licorice and Nicotine Interactions 
Nutrition (including food, herbs, fruit juice and drugs)-drug interactions have recently 
received a wide attention in the clinical investigations research area for in vivo drugs 
kinetics when administrated concurrently with such phytochemicals.  
Pomegranate [74] and licorice [29] are exhibiting a potential inhibition effect for 
CYP3A4, in addition to a minor inhibitory effect by licorice for CYPs of 2B6, 2C9 [29], 
1A2, 2C19 and 2D6 [82], and pomegranate has also a minor inhibitory effect for 
CYP2C9, CYP1A2 and CYP2E1 [77], while Nic metabolism occurs mainly by CYP 2A6 
[23–25], in addition to CYP2B6 [25, 30] and 2A13 [31], which play a minor role under 
certain conditions, especially at high Nic concentrations [28]. 
Table 1.1 Summarizes all CYPs which are responsible about metabolism for each of Nic, 
pomegranate and licorice, where each CYP correlated by tick sign with corresponding 
inhibitor. 
From Table 1.1, there is no common CYP between Nic and pomegranate or licorice in 
the major metabolism path. CYP2B6 plays a minor metabolism role as a common 
metabolizer between Nic and licorice, but it accounts 0.2% of human liver CYPs [29], 
where it metabolizes around 3% of all drugs, and it plays a minor role in Nic metabolism 
[25, 30], especially at high Nic concentrations [28].  
Upon the intensive search from the literature for inhibited CYPs by Nic, pomegranate or 
licorice, there is no inhibitory metabolic competition between Nic and each of 
pomegranate and licorice as summarised in Table 1.1, such interactions for CYP3A4 with 
pomegranate or licorice could induce CYP2A6, that lead to accelerates Nic metabolism, 
and the interactions mechanism for CYP’s with phytochemicals which lead to inhibition 
or induction effect [91, 92] attributes  such outcome.  
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Table 1.1 Correlation of CYPs with corresponding inhibitor. 
 
 
CYP 
 
Nic 
 
Pomegranate 
 
Licorice 
 
Major metabolic path 
3A4  ✔ ✔ 
2A6 ✔   
 
Minor metabolic path 
2A13 ✔   
1A2  ✔ ✔ 
2B6 ✔  ✔ 
2C9  ✔ ✔ 
2C19   ✔ 
2D6   ✔ 
2E1  ✔  
 
 
1.5 Nicotine Analysis in Human 
Nic with its metabolites has long been determined analytically in many applications of 
medicinal, pharmaceutical, environmental and industrial research fields. In vivo 
investigations for Nic is a challenging analytical mission, due to the vast and variable 
application demands, such as matrix separation, sensitivity of lower limit of 
quantification (LLOQ) and validity of  the optimized analytical method. 
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1.5.1 Methods of Extraction 
Excellent methods for Nic determination in human fluids like liquid-liquid (LL) 
extraction [93] and LL-back extraction [38], solid phase extraction (SPE) [94] and micro-
SPE [95] in addition to online-SPE for human tissues [12] and dry blood spots (DBS) 
[96] are reported. Urine direct injection into analytical system was also used for Nic 
determination [97–99], but not possible for plasma or other thick fluids injection.  
Simpler and more economic methods with less extraction steps and higher sample 
throughput are still required to manage large-scale human bio monitoring studies with 
low sample volume.  
Protein direct precipitation with agents like methanol [100], trichloroacetic acid (TCA) 
[101], acetonitrile [102], hydrochloric acid as extraction method for the analytes from 
human fluids has been used for drugs determination in human plasma in many 
applications. The mechanism of action for protein precipitation still not clearly 
understood. But many proposed mechanisms were described protein separation from its 
biological fluid by van-der-Waal’s force between protein molecules and precipitation 
agent or by protein’s dehydration in peripheral layer, which leads to cross-linking 
complexes formation and electrostatic hydrophobic interactions [103]. Another 
mechanism of action for protein precipitation was described by the salting out procedure 
[104]. Figure 1.5 shows how protein constituents were precipitated from human plasma 
by addition 20% w/v of TCA solution to the samples, and figure 1.6 demonstrates how 
protein constituents were precipitated from human semen by addition 20% w/v of TCA 
solution to the samples. 
 
 
Figure 1.5 Illustration for protein direct precipitation procedure applied on human 
plasma sample from the current study. 
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Figure 1.6 Application of protein direct precipitation procedure on human semen sample 
from the current study. 
 
1.5.2 Analytical Techniques 
Many analytical systems have involved in Nic analysis including fluorometric detection 
and postcolumn UV-photoirradiation for Nic and Cot determination in human serum  
[105], high performance liquid chromatography with ultraviolet detection (HPLC-UV) 
for Nic and Cot determination from human plasma [106], colorimetry and immunoassay 
methods for Nic and Cot determination in human saliva, urine, and blood [107], 
comparative radioimmunoassay with LC-MS method for Nic and Cot determination from 
smoker’s serum and saliva [108], liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) for simultaneous determination of Nic and its nine 
metabolites in human urine [98], comparative study between reversed phase (RP) –
HPLC-photodiode array (PDA) with  gas chromatography mass spectrometry (GC-MS) 
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for determination of Nic and Cot in Jordanian smoker's blood and urine [109],  ion trap 
MS with quadrupole time-of-flight (QTOF) MS for Nic characterization with related 
compounds through electrospray ionization (ESI) [110] and hybrid tandem quadrupole 
time of flight (QqTOF) MS was used for simultaneous determination of Nic and its major 
metabolites Cot and trans-3’-hydroxycotnine in human urine [111]. 
 
1.5.3 Orbitrap MS 
 
Orbitrap-MS has first introduced in 2000 [112] by Dr. Alexander Makarov and becomes 
commercially available in 2004 [113]. Orbitrap device consisted from central inner 
electrode which aligned horizontally inside of cylindrically shaped outer electrode as 
shown in Figure 1.7, these electrically charged electrodes are forming a cylindrical hole 
that confines ions revolving around the inner electrode, which allowing fractionation to 
be occur for ions with different m/z values into rings surrounding the electrode through 
their orbital motion [112, 113]. Consequently, the pulsed ions into orbitrap device are 
oscillating along with axial frequencies of 50–150 kHz [114].  
 
Figure 1.7 Schematic diagram for orbitrap mass analyzer with C-Trap device [113, 115]. 
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1.5.4 Dried Blood Spot  
DBS have been used for screening of metabolic disorders in newborns for decades, and 
have already become a popular sampling method for the quantitation of small molecules 
in blood [116]. This technique has more recently been applied to drug metabolism (DM) 
[117], pharmacokinetic (pk) [118], therapeutic drug monitoring (TDM) [119], and 
toxicokinetic (TK) [120] studies. DBS has applied in tobacco smoke research field as 
well as an alternative sampling method for Cot determination in human blood as a 
biomarker for Nic intake in metabolism studies [121], secondhand smokers [122], 
newborn [123]. Recently DBS has also applied in an automated sample extraction system 
for purpose of doping relevant compounds determination, using Nic with its major 
metabolites of nornicotine, Cot and trans-3-HCOT as an applicable example for such 
drugs testing in sport applications [96]. 
The use of DBS technique has increased to manage high population-based studies, 
especially those of large-scale human bio monitoring, as well as studies involving 
children or small animals, since the skin-stick procedure is technically simple and do not 
require extensive training or expensive equipment. Only a tiny volume of blood is 
enough, and handling blood specimens is relatively non-hazardous against pathogens 
risk, such as HIV.  
Many punching-extraction systems are involved in DBS analysis, including the simplest 
punching equipment like manual puncher in figure 1.8 which has used in current study, 
automatic mechanical puncher [124] and automatic puncher by laser [124, 125]. Also the 
extraction methods are vary for the punched DBS such as direct reconstitution in single 
extraction step, which was used in this study as illustrated in figure 1.8. More extraction 
steps are also reported for DBS by LLE [126] and SPE [127] including online SPE [96]. 
The commercially available DBS’s cards are manufactured mainly from cellulose and 
non-cellulose material in a specified thickness and pores. Recently, among these 
commercially available filter cards, few types are approved by United State (US) food 
and drug administration (FDA) for quantitative analysis work, which are Ahlstrom 226-
K062932, Whatman 903 and PerkinElmer 226 [128]. The most recommended filter cards 
for drug metabolism and pharmacokinetics (DMPK) in addition to newborns screening 
and other quantitative routine analysis work are general electronics (GE) Whatman 903 
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FTA cards with its sub-type A, B, C as a satisfactory filter paper for quantitative analysis 
requirements [128].  
 
 
 
Figure 1.8 Illustration for DBS punching and reconstitution procedure from the current 
study.  
 
 
1.5.5 Investigated Nicotine in Human Fluids and Tissues 
Nic is distributed extensively in human body, it was determined with its metabolites in 
smoker’s autopsy tissues of brain, lung, liver, spleen, kidney, skeletal muscle, abdominal, 
thigh, adipose [13], hair  [129], nails, teeth [18] and bones [19]. A limited studies were 
described Nic availability in human solid tissues in spite of its significant levels were 
found, and not as much as those reports for Nic investigation in human fluids, such as 
human plasma [130], saliva [131], urine [132], female breast milk [16] and cervical 
mucus [17]. A significant concentration for Nic and its major metabolites were also found 
in human’s seminal fluid, but limited studies were described its analysis in seminal 
plasma using non- validated analytical method [20–22], and no further studies were 
reported for Nic determination in human semen or sperm.  
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1.6 Bioanalytical Method Validation 
The demands for analytical methods validation was reviewed and discussed in 1991, by 
Karnes et al. [133] and described a guidance for bioanalytical method validation. US 
FDA -center for drug evaluation and research (CDER) - was released their first guidline 
on bioanalytical methods validation in 2001 [134], and discussed validation sections 
including the accebtable criteria, using biological fluids by most analytical techniques 
(such as HPLC, LC-MS, GC and GC-MS). European medicine agency (EMEA) was also 
in agreement with the US FDA’s guideline on bioanalytical method validation. Their first 
released guideline on validation of bioanalytical methods was in 2011 [135], then 
followed by the latest version of EMA in 2013 [136].  
Both of US FDA and EMA are discussing the full validation sections in terms of 
selectivity (specificity), accuracy, precision, linearity and stability. US FDA guideline 
adds more recovery and system suitability sections which are not discussed in EMA. 
According to both guidelines, when some of the method parameters are changed, a partial 
validation could be applied to the methods of which are fully validated. The acceptable 
criteria for measurements accuracy and precision in all validation sections described in 
US FDA and EMA guidelines are in the same range, where ± 15% biased measurement’s 
accuracy are accepted for each quality control (QC) and standard calibrator sample, and ± 
20% biased measurement’s accuracy for LLOQ. The described and discussed validation 
sections in both guidelines as the following: 
 
1.6.1 Selectivity (Specificity) and Carryover  
Specificity of any analytical method is described as the ability of an analytical method to 
quantify the targeted analyte peaks in presence of other components in the sample matrix. 
The specificity of the method should be evaluated by screening six individual sources of 
the appropriate blank matrix, which are individually analyzed as replicates, and evaluated 
for interference with comparison to LLOQ. By roles, the accepted interfering peaks 
should have less than 20% of the LLOQ’s response for the analyte, and 5% for the IS in 
the analyte matrix. Less matrix samples and lower replicate analysis in specificity or 
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selectivity test is allowed in cases of difficultly available matrices, like human semen or 
tissues.  
For sample carryover, the evaluation test occurs mainly to ensure that the rinsing solution 
used to clean up the injection port is able to avoid the injected sample residuals 
efficiently on subsequent injections, especially at high concentration. Carryover test 
should be checked through method development, and its evaluation in the method 
validation should be examined under extreme conditions by injecting blank sample 
following injection of the highest used concentration. Carryover acceptance criteria in the 
subsequent blank sample injection after the upper limit of quantification (ULOQ) 
shouldn’t exceed 20% of the LLOQ and 5% for the internal standard.  
 
1.6.2 Matrix Effect and Recovery 
Sample’s extraction recovery and its matrix effect are the factors that affecting the overall 
analytical signal intensity by sample’s total ions count (TIC). The recovery validation 
section is described by US FDA guideline on bioanalytical method validation, page 
number 6, lines 233-240 [137], but it doesn’t mentioned in guideline for bioanalytical 
method validation of EMA [136].  
To reflect the extraction efficiency for the analytes from their biological matrix, a set of 
extracted QC samples should be analyzed in replicate, then comparing their peak area to 
the corresponding non-extracted ones (prepared by spiking of equivalent amount from 
QC samples in extracted blank). 
The endogenous compounds in any biological matrix could affect the aerosol formation 
efficiency or droplet evaporation in the ion source of mass spectrometry (MS) [138, 139], 
where less volatile matrix components negatively affect the sample evaporation in terms 
of aerosol’s droplet transformation into gaseous phase and releasing free ions as a result.  
Matrix effect should be evaluated by using six different non-pooled sources of biological 
matrix, given freshly from individual donors. 
The matrix impact on ion suppression or ion enhancement should be assessed for each 
targeted analyte including IS at two different QC levels (at low and high levels). In order 
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to determine the matrix factor magnitude, a set of extracted blank matrix should be 
spiked at low and high of QC levels, and compered directly to corresponding prepared 
QC samples in matrix free solvent.    
The differences in analytical signal between injected samples in presence of matrix and in 
absence of matrix are considered as matrix factor (MF), and internal standard-normalized 
MF (IS-NMF) should also be calculated by dividing analyte MF by the measured IS MF. 
The acceptance criteria for the coefficient of variation (CV %) of IS-NMF, calculated 
from the replicate analysis, shouldn’t be more than 15 %.  
 
1.6.3 Calibration Curve Linearity  
The linear relationship of concentration with corresponding instrumental response should 
be studied by regression function over specified concentration points. A calibration curve 
(CC) should be prepared for each analyte studied in the method validation and it should 
be included with each analytical run.  
CC in bioanalytical methods determinations should be established from blank sample 
(extracted blank sample without analytes or IS), zero concentration (extracted blank 
sample with IS) and at least six calibrator samples including LLOQ and ULOQ. The used 
dynamic range for any application should be established upon the expected in vivo 
concentration for the targeted analyte by literature aid, to quantitate most of the designed 
study samples, and the selected LLOQ’s concentration as the lowest analyte level in the 
quantitative CC should be decided upon the investigational targeted level as well. The 
accepted LLOQ’s analytical signal must be more than 5 times of any interfering or 
baseline noise peak, in other words it should has signal to noise ratio more than 5. LLOQ 
measurements have the most tolerant acceptable range, where the acceptance criteria for 
individual measurement accuracy must be more than 80 %, and its replicate analysis CV 
% shouldn’t exceed 20 %.  
The specified concentrations that built up a CC should be back calculated upon the 
established regression function, and the parameters of slope and intercept should be 
reported for at least three CC’s replicate analysis during validation. All calibrators 
18 
 
 
 
accuracy should be within ±15% biased from there specified concentration, and ± 20% 
for LLOQ. At least 75% of the CC’s points with at least six calibrator points as minimum 
acceptable number should satisfy this criterion.  
 
1.6.4 Precision and Accuracy 
Accuracy and precision measurements should be derived from replicate analysis for each 
of QC level in addition to LLOQ, which are independently prepared from different 
working solution of the calibration standards. The biased calculation accuracy for 
individual QC measurements shouldn’t exceed 15% from corresponding specified 
concentration and 20% for LLOQ. The intra-or within-run measurements precision 
should be evaluated from at least five replicate analysis per QC level with a minimum of 
four QC levels including LLOQ, where QC low should be assigned its concentration as 
three times higher than LLOQ, QC mid on the middle of ULOQ and 80% of ULOQ for 
QC high, to cover most of studied dynamic range. The same measurement acceptance 
criteria are applied for QC measurements in all validation sections with respect of the 
biased measurement accuracy (±15% for QC and ±20% for LLOQ). The measurements 
precision should also meet same criteria in terms of CV% (15% for QC and 20% for 
LLOQ). Within single analytical sequence, 67% of QC samples should pass through the 
acceptance criteria. 
The between-run or inter-run accuracy and precision measurements should be evaluated 
by running three sets of within-run sequences. LLOQ measurements accuracy and 
precision are considered as indicator for the method sensitivity. 
  
1.6.5 Stability 
Stability test in bioanalytical method validation is carried out to assure that all steps in 
sample preparation are stable, including repeatable samples re-entry to deep freezer 
(freeze-thaw cycles) and short term storage conditions of pre- and post-samples 
extraction. Samples stability under long term storage conditions should also be studied to 
ensure that long term storage conditions are preservative enough for the samples. 
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Stability evaluations should be carried out in replicate analysis for QC low and QC high 
which are matching storage conditions, then analyzed immediately after each stability test 
with freshly prepared CC. More than 66% of QC replicate analysis should fit within 
measurement accuracy of ±15% after each stability test. 
 
1.7 Work Objectives and Significance 
A new bioanalytical method for determination of Nic, Cot and Nox in human urine, 
plasma, semen and sperm, by using LC-Orbitrap MS should be developed and validated 
in this study, in order to apply three objectives dealing with: 
 
1- Study the Influence of Licorice and Pomegranate Drinks on Nicotine Metabolism 
in Human Urine. 
 
2- Simultaneous determination of nicotine, cotinine and nicotine N-oxide in human 
plasma, semen and sperm by LC-Orbitrap MS.  
 
3-  Determination of nicotine and cotinine in human blood by  
 dried blood spot-LC-Orbitrap MS technique. 
 
For all objectives in this study, twenty-four Jordanian volunteers will be participated in a 
clinical study at Jordan center for pharmaceutical research, Amman, Jordan, (http://jcpr-
jo.com/Home.aspx) to provide their urine samples under designed conditions to first 
objective, synchronized with blood and semen samples from twelve volunteer of them for 
the second study objective in addition to their blood droplets collection over the filter 
cards for the third study objective. 
The applied bioanalytical method in the current objectives will be modified as each 
analytical objective demands, then validated according to European [136] and US [137] 
guideline for bioanalytical method validation.  
 
The significance of first objective entitled “Study the Influence of Licorice and 
Pomegranate Drinks on Nicotine Metabolism in Human Urine” is to evaluate the safely 
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use of pomegranate and licorice with Nic intake. For this study purpose, a clinical study 
will be established including twenty-four healthy smoker volunteers, and early morning 
urine samples will be collected from each participant volunteer under licorice drink 
condition, pomegranate drink condition and control condition in separate periods. A new 
bioanalytical method for simultaneous determination of Nic, Cot and Nox in human urine 
will be developed and validated. 
 
In the second work objective, entitled with “Simultaneous determination of nicotine, 
cotinine and nicotine N-oxide in human plasma, semen and sperm by LC-Orbitrap MS”, 
a twelve healthy smoker volunteers will provide their semen samples synchronized with 
blood samples, and the sperm samples will be separated quantitatively from each 1 ml of 
semen samples from each participant volunteers. Each separate matrix of plasma, semen 
and sperm will be extracted by TCA solution in single extraction step, and Nic, Cot and 
Nox concentrations will be determined in human sperm and correlated corresponding 
levels in semen and plasma samples.  
 
In the third work objective, entitled with “Determination of nicotine and cotinine in 
human blood by dried blood spot/ LC-Orbitrap MS technique” a blood samples will be 
collected and dried onto filter cards as spots, these filter cards are designed especially for 
quantitative drugs analysis. The proposed bioanalytical method by DBS will be validated 
for quantitative analysis of Nic and Cot in human blood following single extraction step, 
and then it will be applied for blood samples collection from twelve healthy and smoker 
volunteers, synchronized with blood samples collection from each participant volunteer 
following a conventional method (taking blood into tubes for plasma separation), then the 
measured Nic and Cot concentrations by DBS techniques will be correlated to 
corresponding measurements by conventional method from plasma analysis. 
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2 Study the Influence of Licorice and Pomegranate Drinks on 
Nicotine Metabolism in Human Urine by LC-Orbitrap MS 
 
 
2.1    Introduction 
Nicotine (Nic) 3-(1-methyl-2-pyrrolidinyl) pyridine (Figure 2.1A) is the major alkaloid 
component in tobacco leaves [1]. It absorbed in lung immediately by smoking [2], 
causing disability and early death [3], due to its addiction and toxicological profile [4,5], 
even it has been used as insecticide due to its poisoning capabilities [6]. Nic metabolism 
occurs in human liver mainly by cytochrome P450 (CYP) 2A6 to its major metabolites of 
cotinine (Cot) and nicotine N-oxide (Nox), in addition to other miner metabolites [7]. 
Also CYP2A13 is responsible about Nic metabolism in certain conditions [8]. Food is 
reported to increase Nic metabolim rate by increased hepatic blood flow [9], and some of 
food items are reported to inhibit CYP2A6 competitively with Nic, like mint drink [10] 
and grapefruit [11]. on the other hand, some of dietary substances like isoflavan and 
glabridin derived from licorice products [12,13] and certain species of flavonoids and 
anthocyanins derived from pomegranate [14,15] could accelerate Nic metabolism by 
induction effect of CYP 3A4, which is mainly metabolizes these phytochemicals. Herein, 
it is a particular of importance to evaluate the influence and safely use of pomegranate or 
licorice products when they consumed concurrently with Nic, where Nicotinell
®
, moist 
plug and loose leaf chew [16] are Nic-licorice combination product, in addition to many 
other commercially available licorice products, like sweets, flavors and herbal medicines 
over worldwide, and such products are subject to influence CYP2A6 activity. In this 
study, we intend to evaluate the influence of pomegranate and licorice test drinks on Nic 
metabolism rate, by measuring urinary Nic/Cot, in addition to measure Nic/Nox as a new 
introduced metabolic index in this study, following a previously reported study design 
[10] for evaluation the effect of mint drink on Nic metabolism as measured by Nic to Cot 
ratio in human urine. Furthermore, a new bioanalytical method was developed and 
validated in this study for simultaneous determination of Nic with its major metabolites 
Cot and Nox in human urine by LC-ESI-orbitrap-MS, providing high resolution and 
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accurate mass measurements, top extraction recovery, following single extraction step 
with short run time (2.3 min), where direct urine injection into LC–MS system was 
reported [17], but with not less than 8 min run time, and multiple extraction steps were 
also reported, like liquid–liquid (LL) extraction [18] and LL-back extraction [10], solid 
phase extraction and micro-SPE [19,20], but more throughput and economic method with 
less extraction steps are still required to manage large-scale human bio monitoring studies 
with low sample volume, short run time and minimum running cost as the current 
described method. 
 
 
2.2 Experimental  
 
2.2.1 Chemicals and reagents 
Nic (purity 98%), Nox (purity 98%) and deuterated nicotine-d3(purity 98%) were 
obtained from Toronto Research Chemical (TRC) Inc. (Toronto, Canada), Cot (purity 
98%) was obtained from Fischer Scientific (Schwerte, Germany), blank of urine samples 
were harvested from non-smoker donors and stored immediately in a freezer at −40◦C 
after centrifugation. Deionized water, methanol and formic acid are in LC/MS-quality 
and purchased from Sigma Aldrich (Schnelldorf, Germany). 
 
2.2.2 Instrumentation 
The LC–MS system was constructed from Exactive bench-top orbitrap mass spectrometer 
(MS) (Thermo Fisher Scientific, Bremen-Germany), equipped with electrospray 
ionization ESI source and protected by a waste/detector Rheodyne divert valve, attached 
to (Accela
TM
) LC system from Thermo Fisher Scientific,1250 Pump model, and 
controlled by Xcalibur 3.0.63 software for data management system. 
 
2.2.2.1 HPLC conditions 
An isocratic elution system was applied by methanol:water:formic acid (10:90:0.1, v/v/v) 
at constant flow rate of 0.4 mL/min through an analytical (Phenomenex, Kinetex-C18 
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column 150 × 2.1 mm, 5  _m). The auto-sampler (AS) tray temperature was set at 5 ◦C, 
and the injection volume was 1  L. 
 
2.2.2.2 Mass spectrometric conditions 
The electrospray ion source was operated in positive ion mode for targeted analytes. The 
adjusted ion source nitrogen gas was sat for sheath, auxiliary and sweep gases flow at 45, 
20, 5 units, respectively. The ion spray voltage was sat at 4500 V and the ion transfer 
capillary temperature at 300◦C. The MS resolution option was sat at high-50,000 @ 2 Hz 
with a mass window of 0.1 D for each analyte (Nic, Cot, Nox and Nic-d3). 
 
2.2.3 Standard solutions, calibration curve and QC Samples 
Stock solutions of 1.0 mg/mL for Nic, Cot, Nox and Nic-d3 as an internal standard (IS) 
were prepared separately in methanol and further diluted in 50% methanol for working 
serial dilution at 50, 100, 200, 500, 1000, 2000 and 3000 ng/mL for Nic, Cot and Nox. 
For preparation of spiked calibration curve, 50 µL of these solutions were added to 450 
µL of urine. Similarly, another set of serial dilution were prepared for quality control 
(QC) samples at 50 ng/mL for LLOQ, 150 ng/mL for QC low, 1500 ng/mL for QC mid 
and 2400 ng/mL for QC high. 
 
2.2.4 Sample preparation 
Each 100 µL of urine sample was transferred to an eppendorf tube and 20 µL from 10 
µg/mL IS solution was added, and vortex mixed, then 500 µL of 10% w/v of TCA 
solution was added and vortex mixed for 30 s, then the mixture was centrifuged for 10 
min at 14,000 rpm by Eppendorf centrifuge (MiniSpin
®
 Plus, 12 × 1.5/2 mL). The 
supernatant was then transferred into an AS vial. 
 
2.2.5 Bioanalytical method validations 
The developed method was validated following the European and United States food and 
drug administration (FDA) guidelines [21,22]. Full validation was achieved for urine 
analysis in terms of specificity, carryover, sensitivity, linearity, accuracy, precision, 
matrix effect, recovery and stability. 
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2.2.5.1    Linearity, accuracy and precision 
Within-run linearity, accuracy and precision were evaluated by running analytical 
sequence containing six replicates of LLOQ, QC low, QC mid and QC high spiked in 
urine, with calibration curve including blank and zero. Between-run linearity, accuracy 
and precision were evaluated by running three sets of within-run sequences in three 
separate days. The linearity was assessed by a weighted (1/x) least squares regression 
function. 
 
2.2.5.2    Ion suppression and matrix effect 
The ion suppression was checked for urine matrix by synchronized injection of extracted 
blank, online through post-column infusion for Nic, Cot and Nox standard solution by T-
connection [23]. Moreover, matrix effect test was achieved from six different sources of 
urine (analytes-free blanks) and expressed in terms of matrix factor (MF) through QC 
low and QC high samples. This was done by comparing the peak area of spiked blank 
with analyte (after extraction) to the peak area in absence of matrix (matrix-free analyte). 
IS normalized MF (IS-N MF) was also calculated by dividing the MF of the analyte by 
the MF of the IS. 
 
2.2.5.3    Recovery and stability 
The recovery of extracted Nic, Cot and Nox was determined in urine by duplicate 
analysis at QC low, QC medium and QC high, and compared their peak area to 
corresponding concentration (prepared by spiking of equivalent amount from QC samples 
in extracted blank). All stability sections in the validation were performed in triplicate 
analysis at QC low and high samples, and calculated upon freshly spiked calibration 
curve. The stock solution and spiked urine samples were kept under room temperature for 
48 h to check short term stability. Freeze–thaw cycle’s stability of the samples was 
obtained over four freeze–thaw cycles by thawing from frozen state at room temperature 
for 1 h and refrozen for 24 h. Other processed QC samples were delayed to 48 h and 
injected to evaluate their stability under AS condition at 5◦C. 
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2.2.6 Preparation of pomegranate juice and licorice drink  
Pomegranate juice was prepared by seeding, the seeds were then filled into fruit squeezer 
machine which doesn’t crash the inner hard seeds, and then the fresh juice was provided 
daily to the volunteers. Licorice drink was prepared from its dry roots. Each kg of licorice 
roots powder was soaked for 6 hr at room temperature in 300 mL of water contains 1 g of 
sodium bicarbonate. The slurry mixture was then diluted by 3 L of drinking water and 
filtered to be provided daily and freshly prepared to the volunteers. 
 
2.2.7 Study Design 
In this study, 24 healthy and smoker Jordanian volunteers were participated and selected 
upon inclusion/exclusion criteria. The informed consent and consent form were obtained 
from all participant volunteers in Jordan center for pharmaceutical research, Amman, 
Jordan. The selected adult males were participant in two groups; twelve volunteers were 
selected for each group of A and B depend on their demographic data in Table 4 
including fagerström score for each volunteer. In an open-label, two-period crossover 
design for each of pomegranate and licorice drink treatment, group A was assigned to 
drink 150 mL of licorice beverage three times a day, for seven successive days in the first 
period, while group B was avoided from licorice products and asked to drink water 
instead of licorice, then both groups were switched their drink treatment in the second 
period. Similarly, after 7-days wash up period, pomegranate fresh juice was provided 
three times a day for each volunteer in group A, and group B were avoided from 
pomegranate products in first period, then both groups were switched their drink 
treatment in subsequent period. Early morning urine samples were collected from all 
volunteers within 30 min and before taking the first cigarette and all samples were then 
frozen immediately at −40 ◦C. The collected samples from avoided test drink group were 
considered as control samples. The frozen samples were then shipped in ice box to 
Germany (Duisburg-Essen University) and kept under −40 ◦C deepfreeze until the 
analysis day. The medicines which have impact on Nic metabolism [1] were avoided, and 
fruit or food items which reported to influence on Nic metabolism was also avoided 
through whole study periods, such as grapefruit [11]. All volunteers asked to smoke their 
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usual preferred tobacco brand excepting those of licorice-tobacco combination products 
during the study.  
 
2.3 Results and discussion 
 
2.3.1   Orbitrap-MS analysis 
Mass spectrum in Figure 2.1 shows m/z molecular ion measurements for Nic, Cot, Nox 
and Nic-d3 (IS), detected by Orbitrap-MS in ESI positive scan mode with high mass 
accuracy, sensitivity and selectivity at m/z 163.1237, 177.1031, 179.1187 and 166.1426, 
respectively, the current mass measurements are in agreement with high resolution 
detection by Q-TOF MS [24]. 
 
 Figure 2.1 Accurate measurements mass spectrum for precursor ions of Nic (A), Nic-d3 
(B), Cot (C) and Nox (D), by Orbitrap-MS ESI positive detection mode. 
 
 
2.3.2 Chromatographic separation specificity  
The optimized chromatographic conditions for Nic, Cot, Nox and IS were good enough 
to obtain sharp peaks with minimum matrix effects and ionic suppression negative peak 
(Figure 2.3), assuring high throughput by short run time. The observed retention times 
from LLOQ chromatogram for Nic, IS, Cot and Nox were at 1.8, 1.79, 2.02 and 1.94 min 
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as shown in Figure 2.2A–D, respectively. The specificity of extracted urine for Nic, Cot 
and Nox determination was indicated from blank analysis in six deferent lots, and all 
samples were clean and no endogenous peaks were observed from urine blank 
chromatogram in Figure 2.2E–H for Nic, IS, Cot and Nox respectively, with comparison 
to corresponding LLOQ chromatogram. 
 
2.3.3 Ion suppression and Matrix effect 
The ionic suppression test indicated a separate analyte peaks as shown in Figure 2.3A for 
analyte’s total ion chromatogram (TIC) from ionic suppressant negative peak that caused 
by urine matrix in Figure 2.3B–D for Nic, Cot and Nox, respectively. Further influences 
for urine matrix were investigated and reported in Table 2.1.  
 
2.3.4 Standard calibration curve linearity 
The calibration dynamic range was linear for Nic, Cot and Nox between 50 and 6000 
ng/mL in urine. Table 2.2 summarizes the linear regression function of y = ax ±b 
parameters for Nic, Cot and Nox for 6 replicates analysis in different analytical runs. The 
linear least squares regression weighted function of 1/x was applied for Nic, Cot and Nox 
calculations. 
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Figure 2.2 Chromatogram for LLOQ (50 ng/ml) of Nic (A), IS (B), Cot (C) and Nox (D), 
with corresponding blank in (E), (F), (G) and (H), respectively, in human urine. 
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Figure 2.3 Synchronized urine blank injection with Post-column infusion for standard 
mixture of Nic (B), Cot (C) and Nox (D), in comparison to TIC for further standard 
mixture injection in (A).  
 
 
Table 2.1 MF and IS-N MF measurements from different sources of urine (analyte-free 
blank), at QC low and QC high.  
 
 MF (n=6) IS-N MF (n=6) 
QC low CV% QC high CV% QC low CV% QC high CV% 
Nic 0.96 5.76 0.92 4.2 1.04 8.61 1.00 7.72 
Cot 0.94 7.50 0.97 4.25 1.02 9.77 1.06 7.81 
Nox 0.96 5.66 0.95 0.26 1.05 8.56 1.04 6.48 
IS 0.92 6.52 0.93 5.42  
 
 
 
 
 
 
 
 
46 
 
 
 
Table 2.2 The linear regression function parameters for the analytes by mean the of 
between run analysis during validation in urine. 
 
Analyte Slope (n=6) Intercept (n=6) R-square (n=6) 
Nic 0.000845 ± 0.000020 -0.000805 ± 0.002419 0.999017 ± 0.000763 
Cot 0.000876 ± 0.000022 -0.007575 ± 0.001225 0.998950 ± 0.000853 
Nox 0.000751 ± 0.000021 -0.000889 ± 0.002332 0.999467 ± 0.000225 
 
 
2.3.5 Within-and between-run sensitivity, accuracy and precision 
Within- and between-run accuracy and precision values for Nic,Cot and Nox 
measurements are given in Table 2.3. 
 
 
Table 2.3 Within- and between-run sensitivity, accuracy and precision for Nic, Cot and 
Nox measurements in LLOQ and QC samples. 
 
Within-run measurements (n=6) 
Nominal 
concentration 
Nic  Cot Nox  
Accuracy % Precision % Accuracy % Precision % Accuracy % Precision % 
LLOQ  99.07 [92-109] 6.67 101.32 [84-119] 12.01 99.95 [89-110] 6.55 
QC Low  103.50 [94-111] 6.44 98.21 [90-110] 7.57 102.50 [91-110] 6.54 
QC mid  100.39 [95-105] 3.35 101.58 [94-107] 6.13 101.88 [90-111] 6.29 
QC high  98.60 [93-106] 4.28 98.16 [91-108] 5.44 100.19 [96-106] 3.79 
Between-run measurements (n=18) 
LLOQ  98.29 [83-109] 5.47 100.59 [83-119] 7.81 100.81 [88-112] 6.21 
QC Low  104.06 [94-111] 4.96 101.24 [90-110] 6.59 101.38 [88-111] 5.90 
QC mid  99.48 [93-108] 3.52 100.23 [87-110] 7.11 101.19 [90-114] 6.26 
QC high  100.57 [89-111] 5.68 98.61 [91-112] 5.04 99.80 [94-106] 3.55 
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2.3.6 Recovery and stability 
The described extraction procedure was extracted the analytes in recovery mean of 100 
± 4% from urine, and it was higher than direct injection of unprocessed urine. Stability 
tests of short term under room temperature, freeze-thawing cycles and post preparation 
under AS conditions for analytes were stable within the specified test time, and the 
calculated accuracies for Nic, Cot and Nox after corresponding stability test were higher 
than 85%. 
 
2.3.7 Study applications 
All participant volunteers had a prior history of smoking, and their demographic data of 
age and body mass index (BMI) including fagerström test [25] have reported in Table 
2.4. All urine samples under licorice and pomegranate drink conditions with correspond-
ing control samples were measured and reported their summary in Table 2.5. The 
measurements of control samples (avoided from test drink) in urine were in agreement 
with previous studies [10,26]. An increased metabolism rate for Nic was observed from 
Table 2.5, indicated from decreased Nic/Cot ratio under pomegranate or licorice drink 
with comparison to their corresponding control conditions, whereas Nic/Cot ratio has 
used as metabolic marker and reflected CYP2A6 activity [10]. Moreover, the increased 
metabolism rate was also observed from decreased Nic/Nox ratio under test drinks, and 
more information about Nic metabolism were obtained from Nic/Nox and Cot/Nox, 
where urinary measurements of Cot/Nox ratio remains almost stable under different drink 
conditions, this approach confirms that both of Cot and Nox have similar metabolic 
pathway. P-values from paired t-test were all less than 0.05 as calculated to correlate 
Nic/metabolite ratio derived from each test drink measurements with its corresponding 
control measurements. 
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Table 2.4 Demographic data for all volunteers as group A and B, including Fagerstrom 
score for Nic dependence on cigarettes. 
 
Group A Group B 
Volunteer 
no 
Age 
(Year) 
mass 
(kg) 
Tall 
(m) 
BMI 
(kg/m2) 
fagerström 
score 
Volunteer 
no 
Age 
(Year) 
Mass 
(kg) 
Tall 
(m) 
BMI 
(kg/m2) 
fagerström 
score 
1 25 110 1.93 29.53 8.00 3 21 65 1.66 23.59 4.00 
2 19 78 1.73 26.06 9.00 4 44 72 1.70 24.91 6.00 
5 38 68 1.73 22.72 9.00 7 27 93 1.78 29.35 7.00 
6 33 88 1.72 29.75 10.00 8 28 62 1.74 20.48 10.00 
9 45 74 1.85 21.62 8.00 11 32 102 1.83 30.46 9.00 
10 29 78 1.69 27.31 9.00 12 39 113 1.93 30.34 9.00 
13 38 83 1.72 28.06 8.00 15 22 68 1.70 23.53 7.00 
14 48 92 1.74 30.39 7.00 16 43 79 1.72 26.70 7.00 
17 41 58 1.77 18.51 2.00 19 46 76 1.92 20.62 4.00 
18 35 103 1.81 31.44 8.00 20 38 78 1.88 22.07 10.00 
21 28 81 1.79 25.28 4.00 23 34 93 1.74 30.72 8.00 
22 44 62 1.88 17.54 7.00 24 47 74 1.81 22.59 9.00 
Mean 35.25 81.25 1.78 25.68 7.42 Mean 35.08 81.25 1.78 25.45 7.50 
STD 8.78 15.45 0.07 4.65 2.27 STD 9.16 15.69 0.09 3.92 2.07 
p (t test) 0.480 0.500 0.455 0.449 0.451       
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Table 2.5 Statistical analysis summery for all volunteer’s urine measurements under 
pomegranate and licorice drink with their corresponding control condition. 
 
 
Pomegranate Control measurements  Measurements under pomegranate drink condition 
Nic Cot Nox Nic/Cot Nic/Nox Cot/Nox Nic Cot Nox Nic/Cot Nic/Nox Cot/Nox 
Mean  
(n=24, ng/mL) 
 
1298 
 
 
1460 
 
 
958 
 
 
0.99 
 
 
1.60 
 
 
1.81 
 
 
862 
 
 
1614 
 
 
1169 
 
 
0.62 
 
 
1.01 
 
 
1.79 
 
STD 774 1032 616 0.39 0.76 1.13 577 941 877 0.50 0.88 0.98 
Min 237 339 126 0.29 0.66 0.76 166 686 267 0.10 0.13 0.38 
Max 2797 3920 2217 1.87 3.32 5.72 1996 3940 3288 2.33 3.88 5.12 
P-(t test) 
         
0.0041 0.0021 0.4659 
 
Licorice control measurements  Measurements under licorice drink condition 
Mean  
(n=24, ng/mL) 
1326 1382 969 0.92 1.47 1.83 804 1710 1107 0.50 0.76 1.78 
STD 1014 521 539 0.55 0.94 0.97 509 941 627 0.32 0.36 0.82 
Min 197 385 137 0.23 0.45 0.79 196 722 347 0.11 0.11 0.66 
Max 4174 2520 2139 1.91 4.43 4.19 1794 3807 2350 1.37 1.69 3.58 
P-(t test) 
         
0.0006 0.0008 0.3974 
 
 
2.4 Conclusion 
The current described method for simultaneous determination of Nic, Cot and Nox in 
human urine by LC-Orbitrap-MS was successfully validated, following single extraction 
step, providing accurate mass measurements, top extraction recovery with short run time. 
Nic metabolism rate was accelerated in presence of licorice or pomegranate test drink, 
indicated from urinary measurements of Nic/Cot ratio, in addition to measure a new 
introduced metabolic marker of Nic/Nox in this study. The graphical illustration (Figure 
2.4) shows the metabolic indexes change against different drink treatment. This is the 
first report demonstrating induced Nic metabolism by the mean of induced CYP2A6 
activity. 
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Figure 2.4 Metabolic index under pomegranate and licorice drink with their 
corresponding control condition in human urine for 24 volunteers. 
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3 Simultaneous determination of nicotine, cotinine, and nicotine N-
oxide in human plasma, semen, and sperm by LC-Orbitrap MS 
 
3.1    Introduction 
Nicotine (Nic) has long been investigated in human body due to its addiction profile [1], 
and smoking cigarettes, which leads to many kind of cancers [2, 3], is an important way 
of intake. Nic shows a toxic effect if taken in high doses [2, 3], even it has been used as 
insecticide due to its poisoning capabilities [4]. In an epidemiological study about the use 
of Swedish type moist snuff [5], no evidence for Nic impact on human health was found, 
but in limited studies smokeless tobacco was correlated to adverse health consequences 
[6]. For example, in vitro-based studies for Nic effect on human health indicated a 
deleterious influence on sperm membrane, DNA integrity, and viability [7], or its 
genotoxic impact on chromosomes of human fetal cells [8]. In addition, an animalbased 
study for Nic oral dose-dependent effect on sperm characteristics and fertility of male rats 
showed a significant decrease in sperm motility and count for treated rates compared to 
untreated control rates [9]. Nic enters the bloodstream immediately by smoking through 
lung absorption, and metabolized in liver mainly by CYP 2A6 to cotinine (Cot), nicotine 
N-oxide (Nox), and other metabolites [10]. Nic was distributed extensively among human 
fluids and tissues and was determined in smoker’s autopsy tissues of the brain, lung, 
liver, kidney, muscle [11, 12], spleen, abdominal, thigh, and adipose [12]. Tricker has 
described the Nic occurrence in human body in details [13], and he also described a 
variety of analytical techniques used in biomarkers determination derived from Nic and 
its metabolites, where most of biological fluids and matrixes were investigated such as 
blood, saliva, urine, hair, breast milk, cervical mucus, follicular fluid, fetal fluids, seminal 
plasma, sweat, toenail, and the deciduous teeth. Limited studies were also reported by 
Tricker’s review [13] for Nic or Cot analysis in seminal plasma [14–16] but without 
validated methods and the determination of Nox. To the best of our knowledge, there 
is no investigation whether Nic or its biomarkers Cot and Nox are available in the sperm 
bodies or not, which could be directly correlated to the human infertility. Recently 
published excellent methods for Nic determination in human fluids like liquid-liquid (LL) 
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extraction [17] and LL-back extraction [18], solid-phase extraction (SPE) [19], and 
micro-SPE [20] in addition to online-SPE for human tissues [11] and dry blood spots [21] 
are reported, but simple and economic methods with less extraction steps and higher 
sample throughput are still required to manage large-scale human biomonitoring studies 
with low sample volume. Therefore, we developed and validated a novel bioanalytical 
method for simultaneous determination of Nic, Cot, and Nox in human plasma, semen, 
and sperm bodies by LC-ESI-orbitrap-MS, following single extraction step from 100 μL 
of sample volume by protein direct precipitation. 
 
3.2    Experimental 
 
3.2.1 Chemicals and reagents 
Nic (purity 98 %), Nox (purity 98 %), and deuterated nicotined3 (purity 98 %) were 
obtained from Toronto Research Chemical (TRC) Inc. (Canada). Cot (purity 98 %) was 
obtained from Fischer Inc.; blank of plasma and semen samples were harvested from 
non-smoker donors and stored immediately in a freezer at −40 °C after centrifugation. 
Plasma was obtained by centrifugation of blood, treated with sodium heparin. 
Deionized water, methanol, and formic acid are in LC/MSquality and purchased from 
Sigma-Aldrich (Germany). 
 
3.2.2 Instrumentation 
The LC–MS system was constructed from benchtop orbitrap mass spectrometer 
(Exactive, Thermo Fisher Scientific, Bremen, Germany), equipped with electrospray 
ionization (ESI) source and protected by a waste/detector Rheodyne divert valve, 
attached to (Accela™) LC system from Thermo Fisher Scientific, 1250 Pump model, and 
controlled by Xcalibur 3.0.63 software for data management system. 
 
 
3.2.2.1 HPLC conditions 
Chromatographic conditions were identical for analysis of plasma, semen, and sperm 
samples. An isocratic elution was applied by methanol:water:formic acid (10:90:0.001, 
57 
 
 
 
v/v/v) at constant flow rate of 0.4 mL/min through an analytical column (Phenomenex, 
Kinetex-C18 column 150 × 2.1 mm, 5 μm). The auto sampler tray temperature was set at 
5 °C, and the injection volume was 2 μL. 
 
3.2.2.2 Mass spectrometric conditions  
The ESI source was operated in positive ion mode for targeted analytes. The adjusted ion 
source nitrogen gas was set for sheath, auxiliary, and sweep gases flow to 45, 20, 5 units, 
respectively. The ion spray voltage was set to 4500 V and the ion transfer capillary 
temperature to 300 °C. The MS resolution option was high at 50,000 at 2 Hz with a mass 
window of 0.1 Da for each analyte (Nic, Cot, Nox, and Nic-d3). 
 
3.2.3 Standard solutions, calibration curve, and QC samples 
Stock solutions of 1.0 mg/mL for Nic, Cot, Nox, and Nic-d3 as an internal standard (IS) 
were prepared separately in methanol and further diluted in 50 % methanol for working 
serial dilution at 5, 10, 20, 40, 80, 150, and 250 ng/mL for Nic and Nox and at 10, 20, 40, 
80, 160, 300, and 500 ng/mL for Cot. For preparation of spiked calibration curves, 50 μL 
of these solutions were added to 450 μL of plasma and semen. Similarly, another set 
of serial dilution were prepared for quality control (QC) samples at 5 ng/mL for LLOQ, 
15 ng/mL for QC low, 125 ng/mL for QC mid, and 200 ng/mL for QC high for Nic and 
Nox and at 10 ng/mL for LLOQ, 30 ng/mL for QC low, 250 ng/mL for QC mid, and 400 
ng/mL for QC high for Cot. For quantitative data calculations, a built up processing 
method was used by processing setup-Xcalibur software, where all targeted analytes were 
identified with respect to corresponding mass, calibration levels, and related IS, then 
the peak area of the analytes was divided over the peak area of IS and plotted against 
specified concentrations to obtain linear regression function with 1/× weighting factor, 
which was applied for unknown samples calculation. 
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3.2.4 Sample preparation 
 
3.2.4.1 Subjects 
Plasma and semen samples were obtained from the clinical research center of the Jordan 
center for pharmaceutical research (JCPR), Amman, from 12 healthy smokers following 
a period of sexual abstinence of at least 3 days. Demographic data including Fagerström 
test are shown in the appendix of online supplementary material. From each volunteer, an 
early morning plasma sample was taken before smoking the first cigarette. Subsequently, 
semen samples were obtained by masturbation. But of course, sperm count among 
volunteers is different, depending on many factors of health, diet, environmental 
considerations, and many other factors [22]. Each 1 mL of semen sample was centrifuged 
at 1500 rpm for 15 min by Eppendorf centrifuge (MiniSpin® Plus, 12 × 1.5/2 mL) to 
avoid damage of sperm bodies. Then, the separated sperm samples were weighted and 
washed twice by gentle shaking with 0.5 mL of water to remove seminal carryover by 
decantation of washing water. Each sperm sample was then mixed quantitatively in 1:2 
(w/v) ratio with 20 % (w/v) of trichloroacetic acid (TCA) solution, containing 50 ng/mL 
of IS. The mixture was vortexed for 2 min in a 2-mL Eppendorf tube, then kept in an 
ultrasonic for 10 min and vortexed again for 2 min before centrifugation at 14,400 rpm. 
The supernatant was then transferred into an autosampler (AS) vial. 
 
3.2.4.2 Semen and plasma extraction 
Each 100 μL of sperm-free semen and plasma sample was mixed quantitatively with 200 
μL of 50 ng/mL nicotine-d3 internal standard (IS) in 1:2 (v/v), where IS solution contains 
20 % (w/v) of TCA solution for protein direct precipitation. The mixture was vortexed 
for 1 min and centrifuged for 10 min at 14,400 rpm. The supernatant was then transferred 
into an AS vial.  
 
3.2.5 Bioanalytical method validations 
The method was validated following the European and US FDA guideline [23, 24]. Full 
validation was achieved for plasma analysis in terms of specificity, carryover, sensitivity, 
linearity, accuracy, precision, matrix effect, recovery, and stability. Partial validation was 
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applied on semen analysis in terms of specificity, matrix effect, recovery, and linearity. 
The outcome acceptance criteria for all validation sections were based upon European 
guideline for bioanalytical method validation [23]. 
 
3.2.5.1 Linearity, accuracy, and precision 
Within-run linearity, accuracy, and precision were evaluated by running analytical 
sequence containing six replicates of LLOQ, QC low, QC mid, and QC high, separately 
for plasma and semen, with calibration curve including blank and zero. Between-run 
linearity, accuracy, and precision were evaluated by running three sets of within-run 
sequences on three separate days for plasma and semen. The linearity was assessed by a 
weighted (1/×) least-squares regression analysis. 
 
3.2.5.2 Matrix effect, recovery and stability 
The ionic suppression was checked for plasma and semen, by parallel injection of 
extracted blank and a constant flow of standard solution, containing 1 μg/mL Nic, Cot, 
and Nox through a T-connection [25]. Matrix effect test was achieved from six different 
sources of plasma and semen (analytes-free blanks). For each analyte and the IS, the 
matrix factor (MF) was expressed through QC low and QC high samples, by calculating 
the ratio of the peak area in the presence of matrix (measured by analyzing blank matrix 
spiked after extraction with analyte) to the peak area in absence of matrix (pure solution 
of the analyte). The IS normalized MF (IS-N MF) was also calculated by dividing the MF 
of the analyte by the MF of the IS. 
Extraction recovery for Nic, Cot, and Nox was determined (duplicate analysis) for plasma 
and semen samples by comparison of the peak areas from extracted QC at low, medium, 
and high, with corresponding unprocessed samples (prepared by spiking of equivalent 
amount from QC samples in extracted blank). 
All stability sections in the validation were performed in triplicate analysis for QC 
samples at low and high levels, and then the measurements were back calculated upon 
freshly spiked calibration curve. The stock solution and spiked plasma samples were kept 
under room temperature for 48 h to check short-term stability. Freeze–thaw cycle’s 
stability of the samples were obtained over four freeze–thaw cycles by thawing from 
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frozen state at room temperature for 1 h and refrozen for 24 h. For another stability test, 
the processed samples were stored for 48 h under AS cooling conditions (5 °C) before 
injection. 
 
3.3    Results and discussion 
 
3.3.1 Orbitrap–MS analysis 
Figure 3.1 shows the analysis of the protonated molecular ions for Nic, Cot, Nox, and 
Nic-d3 (IS) by Orbitrap-MS in ESI positive mode with high mass accuracy, sensitivity, 
and selectivity at m/z 163.1237, 177.1031, 179.1187, and 166.1426, respectively. The 
current mass measurements were in agreement with high-resolution detection by Q-TOF 
MS [26]. 
 
Figure 3.1 Orbitrap mass spectrum with ESI positive detection mode for m/z protonated 
molecular ions of Nic, Cot, Nox and Nic-d3. 
 
3.3.2 Chromatographic separation and matrix effect 
The optimized chromatographic conditions for Nic, Cot, Nox, and IS were good enough 
to obtain sharp peaks with minimum matrix effects and ionic suppression by a short 
analysis time. The retention times for Nic, Cot, and Nox were at 1.8, 2.02, and 1.9 min, 
respectively, as shown in Figure 3.2A, b for LLOQ in plasma and semen, respectively. 
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The specificity of extracted plasma and semen for Nic, Cot, and Nox determination was 
indicated from blank analysis in six different lots. All blank samples were clean, and no 
endogenous interfering peaks were observed from blank screening (Figure 3.2C) 
compared to LLOQ (Figure 3.2B).  
Due the fact of thermal decomposition of N-oxide to its parent amine [27], we checked 
Nox thermal back conversion to Nic which could be induced by heated ion transfer 
capillary by injection of Nox alone, and we did not find any noticeable peak at Nic’s 
mass filter.  
 
Ionic suppression test in Figure 3.3A, b, for plasma and semen, respectively, 
demonstrates that Nic, Cot, and Nox were eluted from the column later than ionic 
suppression negative peak.  
Further matrix was investigated, where both MF and IS-N MF measurements were all 
below 10 % for each analyte in plasma and semen.  
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Figure 3.2 Raw ion chromatograms analyzed in localized accurate mass at high 
resolution (50,000 at 2 Hz) for LLOQ from plasma analysis A, LLOQ from semen 
analysis B, and extracted semen blank chromatogram C. 
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Figure 3.3 Separation of Nic, Cot and Nox in TIC from ionic suppression negative peak 
for plasma (A), and for semen (B). 
 
 
3.3.3 Standard calibration curve linearity 
The calibration dynamic range for Nic and Nox was linear between 5 and 250 ng/mL in 
plasma and semen, and for Cot between 10 and 500 ng/mL. Table 3.1 summarizes the 
linear regression function parameters for Nic, Nox, and Cot in plasma and semen 
analysis. The linear least-squares regression weighted 1/× function was applied for Nic, 
Cot, and Nox calculations. 
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Table 3.1 The linear regression function parameters for Nic, Cot and Nox, in plasma and 
semen analysis during validation. 
 
 
Plasma (n=6) Semen (n=3) 
Analyte Slope (CV %) 
 
Intercept 
 
R (CV %) Slope (CV %) 
 
Intercept 
 
R (CV %) 
Nic 0.0131 (3.89) 
 
0.0147 0.9993 (0.07) 
 
0.0131 (6.13) 
 
0.0179 0.9985 (0.08) 
 
Cot 0.0141 (3.90) 
 
0.0511 0.9981 (0.11) 0.0142 (9.04) 
 
0.0926 0.9968 (0.17) 
 
Nox 0.0121 (4.96) 
 
0.0157 0.9986 (0.08) 
 
0.0123 (7.78) 
 
0.0139 0.9986 (0.09) 
 
 
 
3.3.4 Sensitivity, accuracy, and precision 
 
Accuracy and precision values for Nic, Nox, and Cot measurements in plasma and semen 
during validation are given in Table 3.2. Precision run includes six replicates for LLOQ, 
QC low, QC mid, and QC high. 
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Table 3.2 Within-day measurements accuracy and precision in plasma and semen. 
QC 
level 
Measurements in plasma (ng/mL, n=6) 
Nic Cot Nox 
Spiked Measured 
Accuracy 
% 
CV% Spiked Measured 
Accuracy 
% 
CV% Spiked Measured 
Accuracy 
% 
CV% 
LLOQ 5 4.87 
97.35 
(85-105) 
7.80 10 9.91 
99.09 
(82-113) 
11.17 5 5.13 
102.50 
(87-118) 
10.4 
Low 15 15.65 
104.32 
(96-112) 
5.60 30 30.41 
101.38 
(90-114) 
9.81 15 15.22 
100.13 
(87-114) 
9.17 
Mid 125 121.77 
97.41 
(93-100) 
2.63 250 246.89 
98.76 
(88-106) 
6.42 125 123.42 
98.74 
(92-105) 
4.33 
High 200 197.38 
100.82 
(94-106) 
5.23 400 394.63 
98.66 
(89-104) 
6.44 200 202.07 
101.04 
(91-106) 
5.81 
Measurements in semen (ng/mL, n=6) 
LLOQ 5 5.21 
101.84 
(92-108) 
8.96 10 9.79 
98.39 
(88-110) 
8.81 5 5.07 
99.21 
(90-107) 
8.62 
Low 15 15.66 
103.49 
(97-110) 
5.35 30 31.57 
104.38 
(98-110) 
4.61 15 15.12 
102.49 
(92-110) 
6.55 
Mid 125 124.58 
100.63 
(93-106) 
5.19 250 249.66 
98.54 
(94-107) 
5.64 125 126.60 
100.81 
(93-106) 
4.39 
High 200 198.01 
98.81 
(91-110) 
6.86 400 391.40 
99.22 
(88-106) 
7.66 200 198.08 
98.39 
(95-103) 
4.29 
 
 
3.3.5 Recovery and stability 
Protein direct precipitation by TCA solution in plasma and semen leads to high extraction 
efficiency with recovery values higher than 97 % for each analyte. The described 
recovery test was not applied for sperm samples because solid bodies cannot be 
homogeneously spiked, but to assure that the applied extraction procedure was efficient 
enough for analytes extraction, the extracted sperm samples were extracted again, and no 
detectable peaks were observed in the second extract. 
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For short-term stability, the test under room temperature, freeze-thawing cycles, and post 
preparation at 5 °C show that Nic, Nox, and Cot were stable within the specified test 
time, and the accuracies for Nic, Cot, and Nox after corresponding stability test were 
higher than 85 %. 
 
3.3.6 Application 
The method was successfully applied for analyses of plasma semen and sperm of 
smokers. Nic and Cot were detected in all samples, whereas Nox was below the LLOQ in 
plasma but detectable in all semen samples and 10 of 12 sperm samples (Table 3.3). The 
concentration of Nic and Cot in semen and plasma were largely in agreement with two 
previous studies [15, 28]. Interestingly, Nic was significantly higher in semen compared 
to plasma (2.3-fold, p < 0.001). In sperm, the concentrations of Nic and Cot were in the 
same range as for Nic in plasma, and Nic was significantly lower in sperm compared to 
semen (2.1-fold, p < 0.001). To our knowledge, the presence of Nox in semen as well as 
sperm has not been reported up to now. Nox is routinely detected in urine of smokers, 
snuffers, and even nonsmokers [29] and makes up about 4 % of total nicotine equivalents 
in urine [13]. Figure 3.4C, D, respectively, shows no correlation for Nic and Cot 
concentration between sperm and semen, because many factors are affecting sperm count 
in semen [41]. And there is also only a weak correlation for Nic concentration between 
plasma and semen in Figure 3.4A, but a much better correlation for Cot concentration 
between plasma and semen could be observed in Figure 3.4B, which is in agreement with 
similar work for Nic and Cot correlations between semen and plasma [28]. 
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Table 3.3 Measurements of Nic, Cot and Nox in human plasma, semen and sperm.  
 
Measurements in plasma 
(ng/mL) 
Measurements in semen 
(ng/mL) 
Measurements in sperm 
(ng/mL) 
Subject Nic Cot Nox Nic Cot Nox Nic Cot Nox 
1 10.90 106.85 < LLOQ 19.56 102.95 5.89 15.00 110.00 6.23 
2 23.16 220.18 < LLOQ 48.98 234.53 12.54 11.79 89.82 < LLOQ 
3 18.28 188.11 < LLOQ 23.00 203.82 6.38 13.12 113.84 < LLOQ 
4 17.57 195.05 < LLOQ 53.87 232.47 14.31 21.00 213.40 5.43 
5 34.30 314.75 < LLOQ 76.14 350.98 21.85 26.34 190.19 10.22 
6 25.08 213.52 < LLOQ 56.61 248.38 12.24 14.32 157.78 5.96 
7 13.95 117.03 < LLOQ 44.57 146.74 12.05 17.73 142.90 6.91 
8 29.16 220.87 < LLOQ 77.06 278.29 13.47 28.48 238.77 8.91 
9 16.65 183.24 < LLOQ 57.16 203.53 17.23 21.83 203.58 7.79 
10 23.24 182.29 < LLOQ 43.50 221.00 13.57 48.59 307.26 18.98 
11 23.89 136.30 < LLOQ 38.00 175.12 11.65 33.52 147.79 10.35 
12 33.51 276.49 < LLOQ 81.26 331.68 10.74 43.29 331.19 11.69 
Mean 22.47 196.22 -------- 51.64 227.46 12.66 24.58 187.21 9.25 
STD 7.38 60.49 -------- 19.87 70.80 4.27 12.00 76.26 4.01 
CV% 32.82 30.83 -------- 38.47 31.13 33.69 48.82 40.74 43.41 
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Figure 3.4 Nic correlation between plasma and semen (A), Nic correlation between 
semen and sperm (C), Cot correlation between plasma and semen (B), Cot correlation 
between semen and sperm (D). 
 
 
3.4    Conclusion 
Avery fast LC–MS method was developed and validated for the quantitative analysis of 
Nic and Cot in human plasma, Nic, Cot, and Nox in human sperm and semen. Protein 
direct precipitation in a single extraction step was successfully applied for 100 μL of 
plasma and semen by TCA solution. This is the first time that Nic, Cot, and Nox were 
determined in human sperm and Nox in semen. Nic and Cot were found in sperm samples 
at comparable concentrations to plasma samples. Nox was not detected in plasma at the 
established calibration range, but it was detected in semen and sperm. 
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4 Determination of nicotine and cotinine in human blood by  
dried blood spot- LC-Orbitrap MS technique 
 
4.1    Introduction 
Nicotine (Nic, Figure 4.1) has long been investigated in human body due to its adverse 
health consequence and addiction profile [1]. It has also been used as insecticide due to 
its poisoning capabilities [2]. Nic enters bloodstream immediately through smoking by 
lung absorption [3], and metabolized in liver mainly by CYP 2A6 to cotinine (Cot, Figure 
4.1), and other metabolites. For Nic determination in human blood, a traditional sampling 
procedure of drawing blood by venous cannula or syringe followed by multiple 
processing steps is usually used, but many restrictions of hospitalization demands, ethical 
agreements, and high costs are making challanges in Nic research area from human 
blood. 
Dried blood spot (DBS) have been used technique for screening of metabolic disorders in 
newborns for decades, and have already became a popular sampling method for the 
quantitation of small molecules in blood [4]. Using DBS technique has increased to 
manage high population-based studies, especially those for large-scale human bio 
monitoring, as well as studies involving children or small animals, since the skin-stick 
procedure is technically simple and doesn’t need extensive training or expensive 
equipment, only a tiny volume of blood is enough, and handling blood specimens is 
relatively non-hazardous against pathogens risk, such as HIV. This technique has more 
recently been applied to drug metabolism (DM) [5], pharmacokinetic (pk) [6], therapeutic 
drug monitoring (TDM) [7] and toxicokinetic (TK) [8] studies. DBS has applied in 
tobacco smoke research field as well, to provide an alternative sampling method for Cot 
determination in human blood as a biomarker for Nic intake in metabolism studies [9], 
secondhand smokers [10] and newborn screening [11]. Recently, Tretzel et al. has 
described an excellent application for DBS by automated samples extraction system, for 
determination of doping relevant compounds, using Nic and its major metabolites as an 
example for drugs testing in sport applications [12], which has achieved by multiple 
extraction steps (based on solid phase extraction), relatively low extraction recovery (25-
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40%) and 10 min run time. The current study demonstrates a validated bioanalytical 
method for simultaneous determination of Nic with Cot in human blood based on DBS 
technique, following a single extraction-reconstitution step. Subsequently, the validated 
method was then successfully applied to measure Nic and Cot levels in 12 healthy and 
smoker volunteers, and compared their DBS measurements with corresponding 
measurements from whole plasma (traditional blood sampling procedure), using  LC-
Orbitrap MS technique as a highly accurate and sensitive detection system, to satisfy the 
sensitivity demand of small sample volume, where the current described method has the 
advantages of low running costs, single extraction step through direct reconstitution by 
trichloroacetic acid solution (TCA), short run time (2.5 min) and good extraction 
recovery from DBS. Furthermore, we investigated the influence of chromatographic 
effect for first time in Nic analysis by DBS technique. 
 
4.2    Experimental 
 
4.2.1 Chemicals, reagents and materials 
Nic (purity 98%) and deuterated Nic-d3 (purity 98%) were obtained from Toronto 
research chemical (TRC Inc., Canada). Cot (purity 98%) was obtained from Fischer Inc., 
Germany. Blood blank samples were harvested in heparinized tubes from healthy and 
non-smoker donors. Deionized water, methanol and formic acid are in LC/MS-quality 
and purchased from Sigma Aldrich (Germany). FTA DMPK- filter cards, (Whatman
TM
 
903, US-FDA approved type for quantitative analysis [13]), were obtained from GE 
Healthcare. 
    
4.2.2 Instrumentation 
The LC–MS system was constructed from benchtop Orbitrap-MS (Exactive, Thermo 
Fisher Scientific, Bremen-Germany), equipped with a the heated-electrospray ionization 
source (H-ESI) and protected by a waste/detector Rheodyne divert valve, attached to 
(Accela™) LC system from Thermo Fisher Scientific (1250 Pump model) and controlled 
by Xcalibur 3.0.63 software for data management system. 
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4.2.2.1    HPLC conditions 
An isocratic elution with methanol:water:formic acid (10:90:0.001, v/v/v), delivered at 
constant flow rate of 0.4 mL/min through an analytical Kinetex-C18 column (150 × 2.1 
mm, 5 µm) from of Phenomenex
™
 (Germany) was used. The auto sampler tray 
temperature was set at 5 
°
C and the injection volume was 20 µL. 
 
4.2.2.2 Mass spectrometric conditions 
The heated-electrospray ionization (H-ESI) source was operated in positive scan mode 
was used. The adjusted ion source parameters of nitrogen gas for sheath, auxiliary and 
sweep flow were at 45, 20, 5 unit, respectively. Ion transfer capillary temperature and 
auxiliary gas heating temperature was at 300 °C and 400 °C, respectively. The ion spray 
voltage was set at 4500 V. MS resolution option was sat at high-50000@ 2Hz with a 
mass window of 0.1 D for each analyte (Nic, Cot and Nic-d3). 
 
4.2.3 Standard solutions, calibration curve and QC Samples 
Stock solutions of 1.0 mg/mL for Nic, Cot and Nic-d3 were prepared separately in 
methanol, and further diluted in 50% methanol in order to prepare working serial dilution 
at 5, 10, 20, 40, 80, 150 and 250 ng/mL for Nic and at 10, 20, 40, 80, 160, 300 and 500 
ng/mL for Cot. For preparation of spiked calibration curves 50 μL of these solutions were 
added to 450 μL of blood. Similarly, another set of serial dilution were prepared for 
quality control (QC) samples at 5 ng/mL for LLOQ, 15 ng/mL for QC low, 125 ng/mL 
for QC mid and 200 ng/mL for QC high for Nic and at 10 ng/mL for LLOQ, 30 ng/mL for 
QC low, 250 ng/mL for QC mid and 400 ng/mL for QC high for Cot. 
The DBS for standard and QC samples were prepared from freshly spiked whole blood 
and 60 µL were spotted immediately on filter cards. After that, the spots were dried under 
room temperature for 3 h.   
 
 
4.2.4 Sample preparation 
A single extraction step was followed for DBS analysis from a standard 6.35 mm punch. 
Two punches from each level were placed in a polypropylene micro-centrifuge tube and 
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100 µL of 10 % (w/v) TCA, containing 20 ng/mL IS, were added for extraction. The 
mixture were then vortexed for 1 min and centrifuged for 10 min at 16,400 rpm by 
Eppendorf centrifuge (MiniSpin
®
 Plus, 12 × 1.5/2 mL). The supernatant was then 
transferred into autosampler (AS) micro vial.  
 
4.2.5 Method validations 
The developed DBS-based method was validated following the European Medicines 
Agency (EMA) and United States FDA guideline [14, 15], in terms of specificity, 
carryover, sensitivity, linearity, accuracy, precision, matrix effect, recovery and stability. 
DBS handling process was following a reported procedure [16, 17]. Hematocrit effects 
for Cot were studied by Sosnoff and reported previously [10], and blood spot volume 
effect was also studied previously [18, 19]. A chromatographic effect (or distribution 
effect) for the analytes due to a decentralized DBS punching area was studied in the 
current validation to determine the influence of used filter paper on spread of analytes 
across the spot [17]. 
 
4.2.5.1    Linearity, accuracy and precision 
Within-run linearity, accuracy and precision were evaluated by running analytical 
sequence containing six replicates from each of LLOQ, QC low, QC mid and QC high 
with calibration curve including blank and zero. Between-run linearity, accuracy and 
precision were evaluated by running three sets of within-run sequences in three separate 
analytical batches within two days. For quantitative data calculations, a built up 
processing method was used by processing setup- 
Xcalibur software, where targeted analytes were identified with respect to corresponding 
accurate mass, calibration levels and related IS. The peaks area of the analytes were then 
divided over corresponding IS peak area and plotted against specified concentrations to 
obtain linear regression function using 1/x weighting factor. 
 
4.2.5.2 Ion suppression, matrix effect  
The ion suppression was checked for DBS by synchronized injection of extracted blank, 
online through post-column infusion for Nic and Cot standard solution. The ion 
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suppressed negative peak was then compared to the analytes total ion chromatogram 
(TIC) [20]. Matrix effect test was achieved from six different sources of blood (analytes-
free blanks) and expressed in terms of matrix factor (MF) through QC low and QC high 
samples by calculating the ratio of the peak area in the presence of matrix. This was done 
by comparing the peak area of blank matrix, spiked after extraction with analyte, to the 
peak area in absence of matrix (pure solution of the analyte). The IS normalized MF (IS-
N MF) was also calculated by dividing the MF of the analyte by the MF of the IS.  
 
4.2.5.3 Recovery 
Nic and Cot extraction recovery from DBS was investigated by applying a second 
extraction for the reconstituted punches at QC high level, to assure that first 
reconstitution step has released Nic and Cot in maximum extraction efficiency. 
 
4.2.5.4 Stability     
All stability sections in the validation were performed in triplicate analysis for QC 
samples at low and high levels, the measurements were then back calculated upon freshly 
prepared calibration curve. The stock solution and DBS samples were kept under room 
temperature for 48 h to check their short term stability and the supernatant stability for 
the extracted DBS samples at 5 °C was checked for 48 h. For long term stability another 
set of QC samples were kept in deep freezer at – 20 °C for 3 months before analysis. 
 
4.2.5.5 Chromatographic effect and decentralized DBS punching area  
DBS decentralized punching area could lead to a variable measurement factor, due to the 
interaction possibility of analyte in blood with the used filter paper materials and through 
stretching of liquid blood spot over cards. Such interactions could lead to differences in 
analytes concentration between the center and peripheral areas within a spot. Here, we 
evaluated the chromatographic effect by punching DBS at peripheral areas (but not 
touching the spot edge) in six replicate analysis at QC low and QC high, and then 
compared their measurements to corresponding centralized punched samples.  
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4.3    Results and discussion 
 
4.3.1 Orbitrap–MS analysis 
Figure 4.1 shows the detection of protonated molecular ions for Nic, Cot, and Nic-d3 by 
Orbitrap-MS in H-ESI positive mode, with high mass accuracy, sensitivity and selectivity 
at m/z 163.12354, 177.10287 and 166.14235, respectively. The current mass 
measurements were in agreement with high resolution detection by Q-TOF MS [110]. 
 
 
Figure 4.1 Orbitrap mass spectrums by ESI positive detection mode for protonated 
molecular ions m/z of Nic, Cot and Nic-d3. 
 
4.3.2 Chromatographic separation, ion suppression and matrix effect 
The chromatographic conditions for Nic, Cot and IS were optimized for sharp peaks with 
minimum matrix effects and ion suppression, assuring high throughput by short run time. 
The retention times for Nic and Cot were 1.8 and 2.0 min, respectively, as shown in 
Figure 4.2A for LLOQ by DBS. The specificity of extracted DBS for Nic and Cot 
determination in blood was indicated by analysis the DBS blank from six different blood 
sources. All blank samples were clean and no endogenous interfering peak were observed 
from blank screening (Figure 4.2B) compared to LLOQ (Figure 4.2A).  
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Figure 4.3 demonstrates that Nic and Cot peaks in total ion chromatogram (TIC, Figure 
4.3A) are eluted from the column later than ion suppression negative peaks, where the 
synchronized injection for DBS blank caused a negative peaks through post-column 
infusion for Nic and Cot solution as shown in Figures 4.3 B and C, respectively. More 
information about matrix effect was obtained from Table 4.1 for matrix effect test and 
reported in terms of MF and IS-N MF for each analyte in blood. 
 
 
Table 4.1 MF and IS-N MF for DBS measurements from different sources of human 
blood (analyte-free blank) at QC low and QC high.  
 
 MF (n=6) IS-N MF in plasma (n=6) 
 QC low CV % QC high CV % QC low CV % QC high CV% 
Nic 1.01 1.74 0.99 2.15 1.02 2.18 0.98 1.16 
Cot 1.00 1.98 0.99 2.33 1.01 3.27 0.98 1.60 
IS 0.99 1.59 1.00 2.28  
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Figure 4.2 Chromatograms for LLOQ from DBS analysis (A), and extracted blank from 
DBS (B). 
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Figure 4.3 A comparison TIC chromatogram in A to ionic suppression negative peaks in 
B and C for Nic and Cot, respectively. 
 
 
4.3.3 Standard calibration curve linearity 
The calibration dynamic range for Nic was linear between 5-250 ng/mL. The regression 
function (Y = a + bX) parameters of (a = intercept, b= slope and correlation coefficient 
(R^2)) for Nic (n = 6) were b= 0.0058 ± 0.0001 (relative standard deviation (RSD %) = 
2.4), a = -0.0008 ± 0.0016 and R^2 0.9987 ± 0.0012 (RSD % = 0.12). The calibration 
range for Cot was linear between 10-500 ng/mL, and its regression parameters summary 
(n = 6) were b= 0.0041 ± 0.0002 (RSD % = 4.14), a = -0.0002 ± 0.0029 and R^2= 0.9987 
± 0.0009 (RSD % = 0.09). 
 
4.3.4 Within-and between-run sensitivity, accuracy and precision 
Within- and between-run measurements accuracy for Nic and Cot were all higher than 80 
% for LLOQ and 85 % for QC levels. Within- and between-run measurements precision 
for Nic and Cot were all within 15 % as given in Table 4.2 for precision and accuracy 
measurements for Nic and Cot in three separate analytical batches from DBS analysis 
during validation. Each precision batch includes six replicates for LLOQ, QC low, QC 
mid and QC high.  
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Table 4.2 DBS measurements accuracy and precision for within-batch and between- 
batches analytes during validation. 
 
Within-day measurements (ng/mL, n = 6) 
QC Level 
Nic Cot 
Spiked Measured Accuracy % CV % Spiked Measured Accuracy % CV % 
LLOQ 5 5.27 105.39 (88-114) 10.36 10 9.51 95.08 (81-115) 12.73 
Low 15 15.14 100.94 (91-108) 5.35 30 30.28 100.93 (94-106) 3.99 
Mid 125 121.95 97.56 (93-103) 3.65 250 246.15 98.46 (93-103) 3.12 
High 200 199.16 101.72 (97-107) 12.34 400 388.43 97.11 (95-100) 2.22 
Between-days measurements (ng/mL, n = 18) 
LLOQ 5 5.14 102.85 (88-117) 8.42 10 9.74 97.36 (81-115) 8.54 
Low 15 14.82 98.77 (91-108) 4.35 30 30.95 103.16 (88-115) 6.46 
Mid 125 124.61 99.69 (93-105) 3.53 250 247.15 98.86 (92-114) 4.53 
High 200 201.33 101.37 (97-107) 2.87 400 399.23 97.43 (93-102) 2.41 
 
 
4.3.5 Recovery and stability 
The extraction-reconstitution step by TCA solution for the punched DBS disks was 
efficient enough to recover the analytes from their solid matrix, where the analysis of 
secondly extracted QC high samples showed that no detectable signals for Nic or Cot 
were observed, namely, the highest extraction recovery was reached. For short term 
stability, the test under room temperature and post preparation at 5 °C show that Nic and 
Cot were stable within the specified test time, and the calculated accuracies for Nic and 
Cot were higher than 85 %. 
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4.3.6 Chromatographic effects  
The data obtained from decentralized disk punching (from peripheral areas) within the 
DBS circle was compared to the data obtained from the centralized punching analysis as 
given in Table 4.3. The data indicated that centralized punches had slightly higher 
analytes intensities than the decentralized punches. The accuracy and precision for 
decentralized punching measurements were comparable to corresponding centralized 
punching measurements. Thus, demonstrate that overall chromatographic variation 
compares a minimal variation factor in Nic and Cot quantitation by DBS, as long as the 
punched disks stayed within the confines of the DBS (non-touching the edge). 
 
Table 4.3 Chromatographic effect test by decentralized disk punching for Nic and Cot 
analysis, in terms of measurements accuracy %.  
 
 
 
Centralized punching measurements 
accuracy % 
Decentralized punching measurements 
accuracy % 
Nic Cot Nic Cot 
QC low QC high QC low QC high QC low QC high QC low QC high 
Test 1 100.98 97.44 98.27 95.56 88.971 91.70 101.06 93.69 
Test 2 107.65 106.32 94.54 97.67 99.319 94.54 96.83 95.43 
Test 3 101.43 104.16 101.43 99.74 102.168 94.35 91.16 99.52 
Test 4 102.75 97.93 101.81 94.51 100.392 95.33 90.04 95.05 
Test 5 101.71 103.75 105.94 99.37 94.849 97.06 105.24 95.57 
Test 6 91.09 100.71 103.56 95.79 106.165 101.70 92.03 97.76 
Mean 100.94 101.72 100.93 97.11 98.64 95.78 96.06 96.17 
CV % 5.35 3.54 3.99 2.22 6.09 3.53 6.35 2.18 
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4.3.7 Application 
Early morning blood spots samples were collected from twelve healthy smoking 
volunteers over filter cards in duplicate from their hand’s fingers, following a DBS 
processing protocol [140, 141], synchronized with drawing blood samples into 
heparinized tubes for plasma assay [144]. The collected blood spots were left for 3 h 
under room temperature for drying, and then kept in deep freezer at -20 °C for long term 
storage till analysis. DBS sampling were synchronized with whole blood collection from 
each volunteer in a heparinized tube. These blood samples were separated into plasma 
and kept in deep freezer at -20 °C till analysis.  
The measurements of Nic and Cot in DBS with corresponding measurements from whole 
plasma measurements are listed in Table 4.4.  
 
Long term storage for such volatile compounds (Nic and Cot) could attributes the noticed 
few scattered measurements from Figure 4.4 for DBS compared to corresponding whole 
plasma measurements, but in spite of such long term instability, a good correlation in Nic 
and Cot measurements between both sampling methods was indication from t-test (p < 
0.05) in Table 5, where p -value for Nic and Cot were 0.0051 and 0.0098, respectively.   
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Table 4.4 Measurements of Nic and Cot in human DBS with corresponding 
measurements from whole plasma. 
 
 Measurements by DBS (ng/mL) Measurements from whole plasma (ng/mL) [21] 
Subject Nic Cot Nic Cot 
1 
 
10.82 103.30 10.90 106.85 
2 
 
9.28 123.13 23.16 220.18 
3 
 
8.49 105.76 18.28 188.11 
4 
 
12.94 182.04 17.57 195.05 
5 
 
31.29 271.68 34.30 314.75 
6 
 
16.05 157.93 25.08 213.52 
7 
 
11.65 114.19 13.95 117.03 
8 
 
9.42 100.77 29.16 220.87 
9 
 
15.16 175.83 16.65 183.24 
10 
 
23.51 183.21 23.24 182.29 
11 
 
18.87 128.31 23.89 136.3 
12 
 
29.54 256.74 33.51 276.49 
Mean 
 
16.42 158.57 22.47 196.22 
CV% 
 
47.89 36.68 32.82 30.83 
P ( t-test) 0.0051 0.0098 ------ ------ 
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Figure 4.4 Correlation between DBS measurements with their corresponding 
measurements from whole plasma for Nic (A) and Cot (B).  
 
 
4.4    Conclusion 
A high throughput, economic and simple bioanalytical method was developed and 
validated for the quantitative analysis of Nic and Cot in DBS using LC-Orbitrap MS. 
Single extraction-reconstitution step by TCA solution was successfully applied for DBS 
extraction.  
Chromatographic effect was investigated for first time in this study and demonstrated that 
overall variation account due to the decentralized punching and hematocrit effect 
comprised a minimal variation factor in Nic and Cot quantitation by DBS as long as the 
punched disks stayed within the confines of the DBS (non-touching the edge).  
 
 
 
 
 
88 
 
 
 
References  
 
1.  Benowitz NL (2010) Nicotine Addiction. N Engl J Med 362:2295–2303. doi: 
10.1056/NEJMra0809890 
2.  Ujváry I (1999) Nicotine and Other Insecticidal Alkaloids. Nicotinoid Insectic 
Nicotinic Acetylcholine Recept 29–69. doi: 10.1007/978-4-431-67933-2_2 
3.  Lunell E, Molander L, Ekberg K, Wahren J (2000) Site of nicotine absorption from 
a vapour inhaler--comparison with cigarette smoking. Eur J Clin Pharmacol 
55:737–741. doi: 10.1007/s002280050007 
4.  Li W, Tse FLS (2010) Dried blood spot sampling in combination with LC-MS/MS 
for quantitative analysis of small molecules. Biomed Chromatogr 24:49–65. doi: 
10.1002/bmc.1367 
5.  Murphy SE, Wickham KM, Lindgren BR, Spector LG, Joseph A (2013) Cotinine 
and trans 3’-hydroxycotinine in dried blood spots as biomarkers of tobacco 
exposure and nicotine metabolism. J Expo Sci Environ Epidemiol 23:513–8. doi: 
10.1038/jes.2013.7 
6.  Spooner N, Lad R, Barfield M (2009) Dried blood spots as a sample collection 
technique for the determination of pharmacokinetics in clinical studies: 
Considerations for the validation of a quantitative bioanalytical method. Anal 
Chem 81:1557–1563. doi: 10.1021/ac8022839 
7.  Edelbroek PM, van der Heijden J, Stolk LML (2009) Dried blood spot methods in 
therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit 
31:327–336. doi: 10.1097/FTD.0b013e31819e91ce 
8.  Stove CP, Ingels A-SME, De Kesel PMM, Lambert WE (2012) Dried blood spots 
89 
 
 
 
in toxicology: from the cradle to the grave? Crit Rev Toxicol 42:230–43. doi: 
10.3109/10408444.2011.650790 
9.  Murphy SE, Wickham KM, Lindgren BR, Spector LG, Joseph A (2013) Cotinine 
and trans 3’-hydroxycotinine in dried blood spots as biomarkers of tobacco 
exposure and nicotine metabolism. J Expo Sci Environ Epidemiol 23:513–8. doi: 
10.1038/jes.2013.7 
10.  Sosnoff CS, Bernert JT  (2008) Analysis of cotinine in dried blood spots by LC 
APCI tandem mass spectrometry. 388:228–229. doi: 10.1016/j.cca.2007.10.031 
11.  Spector LG, Hecht SS, Ognjanovic S, Carmella SG, Ross JA (2007) Detection of 
cotinine in newborn dried blood spots. Cancer Epidemiol Biomarkers Prev 
16:1902–1905. doi: 10.1158/1055-9965.EPI-07-0230 
12.  Tretzel L, Thomas A, Piper T, Hedeland M, Geyer H, Schänzer W, Thevis M 
(2016) Fully automated determination of nicotine and its major metabolites in 
whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports 
drug testing. J Pharm Biomed Anal 123:132–140. doi: 10.1016/j.jpba.2016.02.009 
13.  Sharma A, Jaiswal S, Shukla M, Lal J (2014) Dried Blood Spots : Concepts. 
Present Status and Future Perspectives in Bioanalysis. 6:399–414. 
14.  EMA (2012) Guideline on bioanalytical method validation. EMA Guidel. doi: 
EMEA/CHMP/EWP/192217/2009 
15.  U.S. Department of Health and Human Services (2001) Guidance for Industry: 
Bioanalytical Method Validation. doi: 
http://www.labcompliance.de/documents/FDA/FDA-Others/Laboratory/f-507- 
bioanalytical-4252fnl.pdf 
90 
 
 
 
16.  Coombs RW, Investigator P, Fiscus S (2012) Processing of Dried Blood Spots 
Processing of Dried Blood Spots Standard Operating Procedure Procedure 1–20. 
17.  Grüner N , Stambouli O , Ross RS (2015) Dried Blood Spots - Preparing and 
Processing for Use in Immunoassays and in Molecular Techniques. J. Vis. Exp. 
97: e52619, 1-9, doi:10.3791/52619   
18.  Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH, Hannon 
WH (2000) Recoveries of phenylalanine from two sets of dried-blood-spot 
reference materials: Prediction from hematocrit, spot volume, and paper matrix. 
Clin Chem 46:126–128. 
19.  Mei J V, Alexander JR, Adam BW, Hannon WH (2001) Innovative Non- or 
Minimally-Invasive Technologies for Monitoring Health and Nutritional Status in 
Mothers and Young Children Use of Filter Paper for the Collection and Analysis 
of Human Whole Blood Specimens 1. J Nutr 131:1631–1636. 
20.  Annesley TM (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041–
1044. doi: 10.1373/49.7.1041 
21.   Abu-awwad AA, Arafat AT,  Schmitz  OJ (2016) Simultaneous determination of 
nicotine, cotinine, and nicotine N-oxide in human plasma, semen, and sperm by 
LC-Orbitrap MS. Anal Bioanal Chem. doi: 10.1007/s00216-016-9766-7 
 
 
 
 
 
 
 
91 
 
 
 
5 Overall conclusion 
The developed method for simultaneous determination of Nic, Cot and Nox in human 
blood, plasma, urine, semen and sperm using LC ESI-orbitrap-MS was successfully 
validated according to the European and American guidelines for bioanalytical method 
validation, following single extraction step by TCA solution for protein direct 
precipitation, providing top extraction recovery and perfect matrix separation with short 
run time. Accurate mass measurements were obtained by ESI-orbitrap-MS and the 
studied validation sections were all satisfying the acceptance criteria following used 
guidelines. Ion suppression test was achieved and discussed for investigated matrixes and 
showed a perfect separation for matrix’s suppressant compounds from targeted analyte 
peaks. The established method was successfully applied to investigate three objectives in 
current study. 
 
In the first study objective for evaluation of pomegranate and licorice drinks effect on Nic 
metabolism rate as indicated from urinary measurements of Nic/Cot, we found a 
consistent trend of increased metabolism rate for Nic under pomegranate or licorice test 
drink comparing to the corresponding control condition in all participant volunteers urine 
samples (Nic/Cottest drink < Nic/Cotcontrol). More information about Nic metabolism was 
obtained from a new measured metabolic index Nic/Nox, which was introduced for first 
time in this study. Maybe the reason for the accelerated metabolism rate for Nic is that 
induced CYP 2A6 was occurred by CYP 3A4 induction effect, as discussed induction 
effect mechanism in the literatures [91, 92].  
 
The second study objective was intended to investigate Nic and its major metabolites Cot 
and Nox in human plasma, semen and sperm, where Nic has extensive distribution 
among human fluids and tissues, and we found Nic, Cot and Nox for first time in human 
sperm, after quantitative separation of sperm bodies from each 1 mL of semen samples 
by centrifugation as shown in Figure 5.1, then extracted following the optimized method. 
As a result, Nic and Cot were detected in all samples, and Nox was below the LLOQ in 
plasma but detectable in semen samples from 10 of 12 sperm samples. Interestingly, Nic 
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was significantly higher in semen compared to plasma (2.3-fold, p<0.001). In sperm the 
concentrations of Nic and Cot were in the same range as for Nic in plasma and Nic was 
significantly lower in sperm compared to semen (2.1-fold, p<0.001).  
 
 
 
Figure 5.1 Representative separations of sperm bodies as seen in the tube’s bottom from 
whole fluidic semen as achieved in the current study. 
 
The third study objective was intended to find a suitable bioanalytical method for Nic and 
Cot quantification in human blood using DBS technique alternatively to the traditionally 
used methods (using separate plasma from blood), and it was successfully validated for 
simultaneous determination of Nic and Cot following a single extraction-reconstitution 
step by TCA solution for 6.35 mm disk diameter cut out of DBS. Chromatographic effect 
was investigated for first time in this study and demonstrated that overall variation 
account due to the decentralized punching and hematocrit effect comprised a minimal 
variation factor in Nic and Cot quantitation by DBS as long as the punched disks stayed 
within the confines of the DBS (non-touching the edge). The validated method was then 
successfully applied to collect blood samples from twelve smoker volunteers, and 
compared their DBS measurements with the corresponding plasma measurements.  
93 
 
 
 
6 Appendix 
 
6.1 Supplementary material for chapter 3.2.4.1 
 
Abstract 
Here detailed information about the demographic data including Fagerström test of all 
participant volunteers are given. 
Demographic data 
Demographic data including Fagerström test [145] were obtained from all participant 
volunteers (Supplementary material Table 1). 
 Demographic data including Fagerström test for all participant volunteers. 
 
Volunteer no age mass tall BMI Fagerström score 
1 25 110 1.93 29.53 5.00 
2 19 78 1.73 26.06 9.00 
3 21 65 1.66 23.59 4.00 
4 44 72 1.70 24.91 7.00 
5 38 68 1.73 22.72 10.00 
6 33 88 1.72 29.75 10.00 
7 27 93 1.78 29.35 6.00 
8 28 62 1.74 20.48 9.00 
9 45 74 1.85 21.62 8.00 
10 29 78 1.69 27.31 9.00 
11 32 102 1.83 30.46 5.00 
12 39 113 1.93 30.34 9.00 
Mean 31.67 83.58 1.77 26.34 8.17 
STD 8.46 17.46 0.09 3.62 1.75 
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6.2 Preventative calibration curves and function including chromatograms 
 
Nic CC and function including chromatogram from urine analysis 
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Cot CC and function including chromatogram from urine analysis 
 
 
Nox CC and function including chromatogram from urine analysis 
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Nic CC and function including chromatogram from plasma analysis
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Cot CC and function including chromatogram from plasma analysis
 
Nox CC and function including chromatogram from plasma analysis 
 
98 
 
 
 
Nic CC and function including chromatogram from semen analysis
 
 
Cot CC and function including chromatogram from semen analysis
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Nox CC and function including chromatogram from semen analysis
 
Nic CC and function including chromatogram from sperm analysis
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Nic CC and function including chromatogram from DBS analysis
 
 
Cot CC and function including chromatogram from DBS analysis
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6.3 List of abbreviations 
(AS)                 autosampler 
(BMI)               body mass index 
(CC)                 calibration curve 
(CDER)            center for drug evaluation and research 
(CV %)             coefficient of variation 
(Cot)                   cotinine  
(CYP)                 cytochrome p450 
(Da)                  Dalton 
(nicotine-d3)      deuterated nicotine 
(DBS)                 dried blood spot 
(DM)                   drug metabolism   
(DMPK)              Drug Metabolism and Pharmacokinetics 
(ESI)                 electrospray ionization 
(EMA)              European Medicine Agency 
(FDA)                  food and drug administration 
(FT)                   fourier transform 
(FTICR)            fourier transform ion cyclotron resonance 
(FWHM)           full width at half maximum 
(GC-MS)           gas chromatography mass spectrometry 
(GE)                    General Electronics 
(H-ESI)             heated-electrospray ionization source 
(HPLC-UV)      high performance liquid chromatography with ultraviolet detection 
(QqTOF)           hybrid tandem quadrupole time of flight 
(3HC)              3-hydroxy-Cot 
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(IS)                    internal standard 
(IS-NMF)        internal standard-normalized MF  
(JCPR)            Jordan center for pharmaceutical research 
(LL)                 liquid-liquid 
(LC-MS/MS)   liquid chromatography coupled to tandem mass spectrometry 
(LLOQ)           lower limit of quantification 
(m)                  mass 
(Δm)               mass difference 
(Δm50%)               mass difference at the half maximum for two equivalent peaks height 
(MS)               mass spectrometry 
(MF)               matrix factor  
(Nic)                 nicotine  
(Nox)                nicotine N-oxide 
(NRT)             nicotine replacement therapy 
(pk)                   pharmacokinetic 
(PDA)             photodiode array 
(QTOF)           quadrupole time-of-flight 
(QC)               quality control 
(RSD %)         relative standard deviation 
(RP)                reversed phase 
(SPE)              solid phase extraction 
(TDM)              therapeutic drug monitoring 
(TOF)             time of flight 
(TRC)             Toronto Research Chemical 
(TIC)              total ions count 
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(TK)                 toxicokinetic 
(TCA)               trichloroacetic acid solution 
(US)                 United State  
(ULOQ)         upper limit of quantification 
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6.4 List of figures 
Figure 1.1 Chemical structure of Nicotine (Nic, A), Cotinine (Cot, B), Nicotine-N-oxide 
(Nox, C) and deuterated Nicotine (Nic-d3, D). 
Figure 1.2 Percentage quantitative illustration scheme for Nic metabolism, estimated 
from total urinary excretion [26, 27].  
 
Figure 1.3 Chemical structure for phytochemicals derived from pomegranate fruit. 
 
Figure 1.4 Chemical structure for phytochemicals derived from licorice root. 
 
Figure 1.5 Illustration for protein direct precipitation procedure applied on human plasma 
sample from the current study. 
 
Figure 1.6 Application of protein direct precipitation procedure on human semen sample 
from the current study. 
 
Figure 1.7 Schematic diagram for orbitrap mass analyzer with C-Trap device [113, 115]. 
Figure 1.8 Illustration for DBS punching and reconstitution procedure from the current 
study.  
 
Figure 2.1 Accurate measurements mass spectrum for precursor ions of Nic (A), Nic-d3 
(B), Cot (C) and Nox (D), by Orbitrap-MS ESI positive detection mode. 
 
Figure 2.2 Chromatogram for LLOQ (50 ng/ml) of Nic (A), IS (B), Cot (C) and Nox (D), 
with corresponding blank in (E), (F), (G) and (H), respectively, in human urine. 
Figure 2.3 Synchronized urine blank injection with Post-column infusion for standard 
mixture of Nic (B), Cot (C) and Nox (D), in comparison to TIC for further standard 
mixture injection in (A).  
 
Figure 2.4 Metabolic index under pomegranate and licorice drink with their 
corresponding control condition in human urine for 24 volunteers. 
 
Figure 3.1 Orbitrap mass spectrum with ESI positive detection mode for m/z protonated 
molecular ions of Nic, Cot, Nox and Nic-d3. 
 
Figure 3.2 Raw ion chromatograms analyzed in localized accurate mass at high resolution 
(50,000 at 2 Hz) for LLOQ from plasma analysis a, LLOQ from semen analysis b, and 
extracted semen blank chromatogram c. 
 
Figure 3.3 Separation of Nic, Cot and Nox in TIC from ionic suppression negative peak 
for plasma (A), and for semen (B). 
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Figure 3.4 Nic correlation between plasma and semen (A), Nic correlation between 
semen and sperm (C), Cot correlation between plasma and semen (B), Cot correlation 
between semen and sperm (D). 
 
Figure 4.1 Orbitrap mass spectrums by ESI positive detection mode for protonated 
molecular ions m/z of Nic, Cot and Nic-d3. 
 
Figure 4.2 Chromatograms for LLOQ from DBS analysis (A), and extracted blank from 
DBS (B). 
 
Figure 4.4 Correlation between DBS measurements with their corresponding 
measurements from whole plasma for Nic (A) and Cot (B). 
 
Figure 5.1 Representative separation of sperm bodies as seen in the tube’s bottom from 
hole fluidic semen as achieved in the current study. 
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